Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1292 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal Invasive Pulmonary Hemodynamics Predict Outcomes in Exercising Patients Jose, A.
2018
37 4S p. S54
artikel
2 About ISHLT 2018
37 4S p. S9-S10
artikel
3 Abstract Reviewers 2018
37 4S p. S3-S8
artikel
4 Acceptable Peri-Operative Risk for Cardiac Transplant: Physician and Patient Perspectives Savtchenko, A.
2018
37 4S p. S236
artikel
5 Accumulation of Intragraft CD15s+Tregs in Long-term Lung Transplant Survivors O'Sullivan, B.J.
2018
37 4S p. S209
artikel
6 Accurate Quantitative Evaluation of Aortic Insufficiency During LVAD Support by Thermodilution Analysis Akiyama, D.
2018
37 4S p. S382
artikel
7 A Comparison of Inflammatory Profilesin Donor Lungs Following Donation After Brain-Death (DBD) and Donation After Circulatory Death (DCD) Morrison, M.I.
2018
37 4S p. S133
artikel
8 A Comparison of Renal Outcomes in Patients With LVAD and Heart Transplantation Arshad, A.
2018
37 4S p. S467
artikel
9 A Comparison of Short Term Outcomes of Minimally Invasive versus Sternotomy Pulmonary Thromboendarterectomy Higgins, J.R.
2018
37 4S p. S25-S26
artikel
10 A Comparison of Surgical Outcomes for LVAD Implantation by Minimally Invasive Surgery and Conventional Sternotomy Miller, S.D.
2018
37 4S p. S100
artikel
11 A Co-Rhythmic, Isolable, Self-Maintenance, Assist (CoRISMA) Device for Class III Heart Failure Park, J.
2018
37 4S p. S483
artikel
12 Acute Decompensated Heart Failure in the Pediatric Population: A Report from the Pediatric Cardiac Critical Care Consortium (PC4) Lasa, J.J.
2018
37 4S p. S157-S158
artikel
13 Acute Inpatient Rehabilitation Facilitates Post-Implant Recovery of High-Risk LVAS Recipients Lyons, E.N.
2018
37 4S p. S118-S119
artikel
14 Acute Reduction in Pulmonary Artery Pressures with Sacubitril-Valsartan Measured by the CardioMEMS HF Device Raj, L.M.
2018
37 4S p. S313
artikel
15 Acute Skeletal Muscle Wasting and Relation to Physical Function in Patients Requiring Extracorporeal Membrane Oxygenation (ECMO) Hayes, K.
2018
37 4S p. S120
artikel
16 Adherence to Self-care Behaviors After Left Ventricular Assist Device Implantation Ben Gal, T.
2018
37 4S p. S301
artikel
17 Administration of Beta-Blockers Early After LVAD Implantation is Not Associated with Early Right Ventricular Failure or Increased Mortality Derbala, M.H.
2018
37 4S p. S375
artikel
18 Admission and In-hospital Mortality Trends of Heart Failure Patients in the United States from 2001-2014 Briasoulis, A.
2018
37 4S p. S66-S67
artikel
19 A Donor PO2/FiO2 Less Than 300 Does Not Determine Graft Function or Survival After Lung Transplantation Whitford, H.
2018
37 4S p. S247
artikel
20 Advanced Failing Hearts Have a Wide Range of Fibrosis Including Overlap with Nonfailing Hearts Ferrin, P.C.
2018
37 4S p. S231-S232
artikel
21 Advanced Heart Failure Patients With Left Ventricular Assist Devices and Heart Transplantation Have Altered Oral Microbial Diversity Alongside Endotoxemia, Inflammation and Oxidative Stress Yuzefpolskaya, M.
2018
37 4S p. S126
artikel
22 Advanced Heart Failure Therapies in Patients Aged ≥65 Years: Ventricular Assist Device vs. Heart Transplantation Harmon, D.M.
2018
37 4S p. S432
artikel
23 Advanced Parameters of Cardiac Function Out Perform Traditional Echocardiographic Indices in the Identification of Pediatric Patients with Acute Antibody-Mediated Cardiac Transplant Rejection De Angelis, D.
2018
37 4S p. S394
artikel
24 Adverse Events and Their Effect on Quality of Life and Functional Capacity in the ENDURANCE and ENDURANCE Supplemental Trials Rogers, J.G.
2018
37 4S p. S475
artikel
25 A Five-year Experience in Peritheral Veno-Arterial Extracorporeal Membarne Oxygeanation as a Method of Mechanical Circulatory Support in Heart Transplant Candidates Poptsov, V.N.
2018
37 4S p. S286
artikel
26 After Clinical Lung Transplantation, NK Cells with a Lung-Resident Phenotype Represent the Most Prominent Donor Passenger Leukocyte Subset BellmasSanz, R.
2018
37 4S p. S210
artikel
27 After the Referral: How Patients Fare After Evaluation for Left Ventricular Assist Device Placement Yu, S.N.
2018
37 4S p. S464
artikel
28 Ageing and Ischaemic Tolerance in a Rodent Donation After Circulatory Death (DCD) Model Chew, H.
2018
37 4S p. S229
artikel
29 Age-Related Risk of Adverse Events after Left Ventricular Assist Device Implantation: A Device-Specific Comparison Poddi, S.
2018
37 4S p. S367-S368
artikel
30 Air Trapping on Lung Scintigraphy After Lung Transplantation: Predictors and Association with Survival Garcia, H.
2018
37 4S p. S448
artikel
31 Airway Clearance Following Lung Transplant: Current UK Practice Shkurka, E.
2018
37 4S p. S296-S297
artikel
32 Alleviation of VAD Coordinator Time Burden and Empowermentof HVAD Patients in Order to Improve Outcomes Schlöglhofer, T.
2018
37 4S p. S294-S295
artikel
33 Alloimmunity Contributes to and is Enhanced by Acute Lung Injury Following Prolonged Ischemia in Mouse Orthotopic Lung Transplantation Watanabe, T.
2018
37 4S p. S214
artikel
34 Alpha 1 Antitrypsin to Prevent Ischemia Repercusión Injury in a Pig Lung Transplant Survival Model Mariscal, A.
2018
37 4S p. S81
artikel
35 Alteration of the Intestinal Microbiome in Pediatric Heart Transplant Patients is Associated with Diarrhea Spinner, J.A.
2018
37 4S p. S64
artikel
36 Alternative Outflow Graft Placement During Thoracotomy Implant of the HVAD System for the Treatment of Advanced Heart Failure Zimpfer, D.
2018
37 4S p. S146
artikel
37 Ambulatory Counter Pulsation at Home- A Dream that Became a Reality LaBuhn, C.
2018
37 4S p. S259-S260
artikel
38 Ambulatory Counterpulsation with a Minimally Invasive Circulatory Assist Device - Expanding Indications and Extending Support Jeevanandam, V.
2018
37 4S p. S85
artikel
39 Ambulatory Status Improves Outcomes in Patients Bridged to Lung Transplantation with ECMO Bailey, K.L.
2018
37 4S p. S253
artikel
40 A Mouse Model of Recovery from Non-Ischemic Heart Failure Cruz-Solbes, A.S.
2018
37 4S p. S232
artikel
41 A Multidisciplinary Continuous Support Heart Team Approach Improves Hemocompatibility Related Outcomes in Continuous Flow LVAD Recipients Shah, A.M.
2018
37 4S p. S163
artikel
42 A Multidisciplinary Continuous Support Heart Team Approach Improves Survival in Continuous Flow LVAD Recipients Shah, A.M.
2018
37 4S p. S84-S85
artikel
43 Analyzing Geographic Disparities in the US Heart Allocation System Rivard, A.
2018
37 4S p. S342
artikel
44 An Analysis of Preceding Signals and Treatment Strategies of VAD Thrombus in the ENDURANCE and ENDURANCE SUPPLEMENTAL Trials Pagani, F.D.
2018
37 4S p. S57
artikel
45 Anastomotic Outcomes in Idiopathic Pulmonary Fibrosis Patients Receiving Anti-Fibrotic Therapy: Experience of the Australian Lung Transplant Collaborative Mackintosh, J.
2018
37 4S p. S89-S90
artikel
46 3-and 5-Year Results of Lung Preservation with the Organ Care System: Insights from a Single-Center Experience Ius, F.
2018
37 4S p. S243
artikel
47 A Near Point of Care Test for Interleukin 1B During Human Ex-Vivo Lung Perfusion Andreasson, A.S.
2018
37 4S p. S55-S56
artikel
48 A New Combined Model for End-Stage Liver Disease Excluding INR (CMELD-XI) Score Better Predicts Pediatric Heart Transplant Outcomes Choudhry, S.
2018
37 4S p. S98-S99
artikel
49 A New Ex-Vivo Working Heart Model without Ischemia-Reperfusion Damage to Analyze Electrophysiological Properties of a Denervated Heart Bernhardt, A.M.
2018
37 4S p. S226-S227
artikel
50 A New Prediction Model for Quantifying Mortality Risk in Congenital Heart Disease(CHD) Patients after Heart Transplant (HTx) Burchill, L.J.
2018
37 4S p. S392
artikel
51 Angiodysplastic Lesions in the Gastrointestinal Tract of Heart Failure Patients Predates Post LVAD Bleeding Patel, S.R.
2018
37 4S p. S71-S72
artikel
52 An International Survey of LVAD Hygeine Practices Kaan, A.
2018
37 4S p. S298
artikel
53 A Non-cuff Surgical Technique and Potent Peri-Transplant Immunomodulation Together Promote Long-term Survival of Murine Orthotopic Lung Allografts Wang, L.
2018
37 4S p. S217
artikel
54 Anonymous Survey Reveals Low Controller Change Knowledge Among HeartMate II Patients and Caregivers Thompson, M.A.
2018
37 4S p. S270
artikel
55 A Nordic Multicenter Study on Size Mismatch in Bilateral Lung Transplantation Auråen, H.
2018
37 4S p. S166
artikel
56 A Novel Driveline Stabilisation Technique for VAD Özçobanoğlu, S.
2018
37 4S p. S479-S480
artikel
57 A Novel Parameter of Lung Evaluation Utilizing PaO2/FiO2 Difference at the Different FiO2 in Ex Vivo Lung Perfusion Niikawa, H.
2018
37 4S p. S148
artikel
58 A Novel Predictive Risk Score for Gastrointestinal Bleed Following Implantation of Continuous Flow Left Ventricular Assist Device Yin, M.
2018
37 4S p. S365
artikel
59 A Novel Readmission Risk Score is Highly Predictive of Mortality after Heart Failure Admission Cogswell, R.
2018
37 4S p. S42
artikel
60 A Novel Recipient Risk Score to Predict 1-Year Mortality in Pediatric Heart Transplantation Fraser, C.D.
2018
37 4S p. S97-S98
artikel
61 A Novel Risk Model to Predict Right Ventricular Failure after Continuous Flow Left Ventricular Assist Device Implantation Loforte, A.
2018
37 4S p. S370
artikel
62 A Novel Risk Prediction Model for PTLD in the Post Cardiac Transplantation Population: A UNOS Database Analysis Nair, N.
2018
37 4S p. S36-S37
artikel
63 A Novel Transplant RiskScore (TRS) Incorporating Recipient and Donor Variables and Center Effect Jasseron, C.
2018
37 4S p. S182
artikel
64 Antibodies to Lung Self-antigens in Lung Transplant Recipients and Implications for Outcomes Kaza, V.
2018
37 4S p. S218
artikel
65 Antibody-mediated Rejection: Should We Wait for Clinical Diagnosis? Agbor-Enoh, S.
2018
37 4S p. S16
artikel
66 Antimicrobial Prophylaxis for Left Ventricular Assist Device Implantation: Comparing Infection Rates with Single or Multiple Drug Regimens Schubert, S.A.
2018
37 4S p. S135-S136
artikel
67 An Under-Recognized Cause of Malnutrition After Lung Transplant Howsare, M.
2018
37 4S p. S140-S141
artikel
68 A Phase 2b Randomized Controlled Trial of Presatovir, an Oral RSV Fusion Inhibitor, for the Treatment of Respiratory Syncytial Virus (RSV) in Lung Transplant (LT) Recipients Gottlieb, J.
2018
37 4S p. S155
artikel
69 Application of Bayesian Model to Predict Outcomes in Pulmonary Arterial Hypertension Kanwar, M.
2018
37 4S p. S207
artikel
70 A Prospective Comparison of Veno-Arterial Extra-Corporeal Membrane Oxygenation and a Percutaneous Ventricular Assist Device for Cardiogenic Shock Following Acute Myocardial Infarction Garan, A.R.
2018
37 4S p. S263
artikel
71 A Prospective, Randomized, Placebo-controlled Trial of Pre-transplant and Prompt Post-transplant Treatment With Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation (NCT01915082) Vos, R.
2018
37 4S p. S88
artikel
72 A Prospective Study of Coagulation Profile in Lung Transplantation Saez-Gimenez, B.
2018
37 4S p. S111
artikel
73 A Prospective Validation of the First Endoscopic Management Algorithm for Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices Axelrad, J.E.
2018
37 4S p. S161-S162
artikel
74 A Randomized Comparison of T3 vs. T4 for Management of Hemodynamically Unstable Brain-dead Organ Donors Dhar, R.
2018
37 4S p. S342
artikel
75 A Randomized Controlled Trial of Naloxone for Optimization of Hypoxemia in Lung Donors Dhar, R.
2018
37 4S p. S88
artikel
76 Are Elevated Serum Hemolysis Markers a Harbinger of Thromboembolic Events in Heartmate II Patients? Zayat, R.
2018
37 4S p. S365
artikel
77 Are Protocol Driven Biopsies After Steroid Cessation Necessary? Grant, J.F.
2018
37 4S p. S332
artikel
78 A Risk Model Incorporating Pectoralis Muscle Measures More Accurately Risk Predicts Mortality after Left Ventricular Assist Device Implantation Teigen, L.M.
2018
37 4S p. S463
artikel
79 A Single Center Experience: Four Cases of Late Twisting of Outflow Grafts in HeartMate 3 Mueller, M.
2018
37 4S p. S146
artikel
80 A Single Center Experience of the Impella RP in Acute Right Ventricular Failure Proudfoot, A.
2018
37 4S p. S262
artikel
81 A Single Centre UK Experience of Incorporating Urgently Listed Inotrope and Ventricular Assist Device Patients into a Cardiac Rehabilitation Programme Pre-Transplant Probert, H.
2018
37 4S p. S119-S120
artikel
82 Assessing the Need for Palliative Care in LVAD and HTX Patients Strangl, F.
2018
37 4S p. S37
artikel
83 Assessing the Predictive Validity of ISHLT's Primary Graft Dysfunction Classification Instrument Foroutan, F.
2018
37 4S p. S34-S35
artikel
84 Assessment of Myocardial Strain Using Speckle Tracking Echocardiography Within the First 12 Months After Orthotopic Heart Transplantation Antończyk, K.
2018
37 4S p. S331-S332
artikel
85 Assessment of Need for Quality Improvement in Transitional Care Lim, H.M.
2018
37 4S p. S297
artikel
86 Association Between Angiotensin II Receptor Blockade and Recurrent Gastrointestinal Bleeding on Left Ventricular Assist Device Support Schultz, J.N.
2018
37 4S p. S163
artikel
87 Association Between Common Measures of Graft Function and Mortality Post Heart Transplant (HT) Foroutan, F.
2018
37 4S p. S35
artikel
88 Association between Multidimensional Molecular Biomarkers and Functional Recovery Potential in Advanced Heart Failure Bao, T.
2018
37 4S p. S292-S293
artikel
89 Association Between Tacrolimus Concentration/Dose Ratio and Renal Function Following Cardiac Transplant Lourenco, L.M.
2018
37 4S p. S306
artikel
90 Association of Comorbid Conditions and Quality of Life in Ambulatory Heart Failure Patients: A Report From REVIVAL Cascino, T.
2018
37 4S p. S68
artikel
91 Association of Gene Polymorphisms with Thrombosis and Bleeding in Patients with Mechanical Circulatory System Bekbossynova, M.
2018
37 4S p. S288-S289
artikel
92 A Study for Bridge to Lung Transplant with Extracorporeal Membrane Oxygenation Yoshizumi, T.
2018
37 4S p. S253-S254
artikel
93 A “Thrombo-Endarterectomy” Approach: Establishing a New Center for CTEPH Patients Toyoda, Y.
2018
37 4S p. S487
artikel
94 Atrial Fibrillation Burden in Patients with Left Ventricular Assist Devices: Analysis from ICDs Brisco-Bacik, M.A.
2018
37 4S p. S129-S130
artikel
95 Atrial Fibrillation Increases Risk of Recurrent Heart Failure Readmissions in LVAD Patients Wehbe, R.M.
2018
37 4S p. S380-S381
artikel
96 Atrial Fibrillation is Associated With Early Right Ventricular Failure Post-LVAD Koh, S.
2018
37 4S p. S131
artikel
97 Augmentation of Right Ventricular Ejection Against Elevated Afterloads Using a Novel Soft Robotic Device Wamala, I.
2018
37 4S p. S260-S261
artikel
98 Average Daily Dose of Mycophenolate Mofetil in the First Post-transplant Year and Long Term Clinical Outcomes: A Single Center Retrospective Study WONG, K.
2018
37 4S p. S420
artikel
99 Axial Flow Left Ventricular Assist Device is Associated with Progression of Aortic Valve Insufficiency Masood, M.F.
2018
37 4S p. S284-S285
artikel
100 Bacteriophage Treatment in a Lung Transplant Recipient Aslam, S.
2018
37 4S p. S155-S156
artikel
101 Bariatric Surgery in Patients with Continuous Flow Left Ventricular Assist Devices Lamba, H.K.
2018
37 4S p. S385-S386
artikel
102 Barriers to Adherence with Early Postoperative Bridging Anticoagulation Protocols Following LVAS Implantation Frankel, K.A.
2018
37 4S p. S383
artikel
103 Baseline and 1-year Follow-up Serial Optical Coherence Tomography Evaluation of Coronary Plaques in Heart Transplant Recipients Tsukamoto, Y.
2018
37 4S p. S412
artikel
104 Bayesian Model for Predicting 90 Day Event Free Survival in LVAD Patients Kanwar, M.
2018
37 4S p. S193
artikel
105 Benefit of Modified Bicaval Anastomosis Technique for Orthotopic Heart Transplantation From Size-mismatch Marginal Donor Kakuta, T.
2018
37 4S p. S430-S431
artikel
106 Benefits of Early Everolimus-Based Quadruple Immunosuppression Early After Lung Transplantation - Results of 4EVERLUNG, a Prospective Randomized Multicenter Trial Gottlieb, J.
2018
37 4S p. S27-S28
artikel
107 Berlin Heart Excor as Bridge to Heart Transplantation. A Versatile Option in Patients Not Suitable for a Continuous Flow LVAD Bartfay, S.
2018
37 4S p. S271
artikel
108 Berlin Heart Outcomes in Single Ventricle Patients: Where are we Now? Dykes, J.C.
2018
37 4S p. S102
artikel
109 Better Survival Post Lung Transplantation in Cystic Fibrosis Despite Multidrug Antibiotic Resistance in Patients with Previous Achromobacter Colonization de Verdière, S. Colin
2018
37 4S p. S357
artikel
110 Bilateral Living-donor Lobar Lung Transplantation May Deliver Potential Lung Function Kayawake, H.
2018
37 4S p. S454
artikel
111 Bile Acid Aspiration is Associated with Airway Infections: A Targeted Metabolomic Approach Urso, A.
2018
37 4S p. S462
artikel
112 Bile Acids Aspiration Modulates Cholinergic and Serotonergic Responses of the Distal Airways Urso, A.
2018
37 4S p. S214-S215
artikel
113 Biomarker Discovery in Cardiac Allograft Vasculopathy: Novel Aptamer Proteomic and MicroRNA Profiling Almufleh, A.
2018
37 4S p. S413
artikel
114 Biomarkers and Donor Selection in Heart Transplantation Vorlat, A.
2018
37 4S p. S340
artikel
115 Blood Group O Heart Transplant Waitlist Mortality in the Ventricular Assist Device Era Trivedi, J.
2018
37 4S p. S465
artikel
116 Blood Group O is Associated with Decreased Rates of Transplantation and Increased Waitlist Mortality in Lung Transplantation: A Propensity-Matched Registry Analysis Barc, Y.
2018
37 4S p. S167
artikel
117 Blood Pressure Control as a Risk Factor for Stroke in LVAD Patients- Single Center Experience Clarke, N.S.
2018
37 4S p. S31
artikel
118 Blood Pressure Management Ameliorates the Severity of Neurological Events Teuteberg, J.J.
2018
37 4S p. S11
artikel
119 Bloodstream Infections in Left Ventricular Assist Device Recipients Awaiting Transplantation Kyvernitakis, A.
2018
37 4S p. S135
artikel
120 BLTX on Intraoperative ECMO Sets the New Benchmark for Postoperative Graft Function: Results of a Prospective Trial Hoetzenecker, K.
2018
37 4S p. S167-S168
artikel
121 BMI and Association with Outcomes in Pediatric Patients on Durable Ventricular Assist Device Support Puri, K.
2018
37 4S p. S405-S406
artikel
122 Board of Directors 2018
37 4S p. S1
artikel
123 Body Composition Measurement Methods in Systolic Heart Failure Patients Receiving Left Ventricular Assist Devices Vest, A.R.
2018
37 4S p. S273-S274
artikel
124 BOLT Score - A New Prognostic Score for Predicting Survival to Transplant Among Patients on LVAD Support Yoeli, D.
2018
37 4S p. S269
artikel
125 Breaking the Viral Spiral: Changing how you C Hepatitis Miller, T.E.
2018
37 4S p. S77
artikel
126 Bridge to Cancer Therapy: Can LVAD Support Allow Advanced Heart Failure Patients to Survive Cancer Treatment? Raikhelkar, J.
2018
37 4S p. S462
artikel
127 Bridge to Transplant with Continuous Flow Left Ventricular Assist Devices Increases Risk for Severe Primary Graft Dysfunction Truby, L.K.
2018
37 4S p. S328
artikel
128 Bridging to Heart Transplantation (BTT) in Seputagenarians with LVADs Salimbangon, A.
2018
37 4S p. S289-S290
artikel
129 Brincidofovir - Finally an Option for PML? Schneider, J.A.
2018
37 4S p. S358
artikel
130 Bronchial-arterial-circulation-sparing (BACS) Lung Preservation: A Novel Strategy in Lung Transplantation Tane, S.
2018
37 4S p. S225-S226
artikel
131 Bronchial Complications in Contemporary Lung Transplantation: A Rare Event in a 5-Year Single Center Study Mariscal, A.
2018
37 4S p. S252
artikel
132 Bronchiolitis Obliterans Syndrome in Lung Transplantation: A Predictive Model Khurshudyan, A.
2018
37 4S p. S445
artikel
133 Bronchoalveolar Lavage Fluid Proteome in Chronic Lung Allograft Dysfunction Todd, J.L.
2018
37 4S p. S204
artikel
134 Bronchoalveolar Lavage Practices in Lung Transplantation: Results of a Large-scale International Survey Koutsokera, A.
2018
37 4S p. S198
artikel
135 Bronchoscopic Management of Bronchial Anastomotic Defects Using Acellular Cadaveric Dermal Grafts Bedi, H.
2018
37 4S p. S251-S252
artikel
136 Burden and Consequences of Retained Cardiovascular Implantable Electronic Device Lead Fragments After Heart Transplantation Alvarez, P.
2018
37 4S p. S352
artikel
137 By Molecular Analysis, Many ISHLT Histologic Rejection Diagnoses Are Associated With Molecular Injury, Not Molecular Rejection Reeve, J.
2018
37 4S p. S79-S80
artikel
138 Can a More Rapid "Time to Therapeutic INR" Reduce Adverse Events After CF-LVAD Implantation? A Single Center Study Michaud, C.
2018
37 4S p. S162-S163
artikel
139 Can Prolonged Become Too Long? Medical Futility and Duration of Hospitalization Following Lung Transplantation Courtwright, A.
2018
37 4S p. S238-S239
artikel
140 Can Routine Laboratory Values Predict 30-Day Survival of Patients after Cardiac Surgery Requiring ECMO-Support? Neumann, N.
2018
37 4S p. S287
artikel
141 Cardiac Allocation Score: A Survival-Benefit Model for Heart Transplantation Xing, E.Z.
2018
37 4S p. S181
artikel
142 Cardiac Allograft Survival Stratified by Preservation Solution: A Multi-Institutional Analysis Pietras, C.
2018
37 4S p. S346
artikel
143 Cardiac Power for Prediction of Outcomes in Patients with LVADs Guglin, M.
2018
37 4S p. S179
artikel
144 Cardiac Recovery in Patients with Adriamycin-Induced Cardiomyopathy After Left Ventricular Assist Device Support Coromilas, E.J.
2018
37 4S p. S269-S270
artikel
145 Cardiac Resynchronization Therapy and Outcomes in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-analysis Voruganti, D.C.
2018
37 4S p. S130-S131
artikel
146 Cardiac Transplantation and Mechanical Circulatory Support in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Madan, S.
2018
37 4S p. S422
artikel
147 Cardiac Transplantation From Non-viremic Hepatitis C Donors Patel, S.R.
2018
37 4S p. S137
artikel
148 Cardiac Transplantation with Delayed Autologous Stem Cell Transplant in Patients with Cardiac Amyloidosis Trachtenberg, B.H.
2018
37 4S p. S92-S93
artikel
149 Cardiopulmonary Bypass Use Does Not Affect Outcomes in Single Lung Transplantation Iyengar, A.
2018
37 4S p. S453
artikel
150 Cardiopulmonary Exercise Testing to Validate Pump Speed Optimization in Patients Implanted With HM 3 Montalto, A.
2018
37 4S p. S286
artikel
151 Cardiovascular Autonomic Control in End Stage Lung Disease Before Lung Transplantation Morlacchi, L.
2018
37 4S p. S457-S458
artikel
152 Cardiovascular Magnetic Resonance Imaging for Risk Assessment and Prediction of Clinical Worsening in Pulmonary Arterial Hypertension Göransson, C.
2018
37 4S p. S490
artikel
153 Case of Combined Heart-Kidney Transplant from Hepatitis C (+) Donor to a HCV (-) Recipient Wettersten, N.
2018
37 4S p. S139
artikel
154 Cause of Death Among Bridge to Transplant and Destination Therapy LVAD Patients in a Large, Single Center Cohort Schultz, J.N.
2018
37 4S p. S380
artikel
155 CD8-Expressing Transitional B Cells Dominate B Cell Reconstitution after Mixed Chimerism Conditioning for Thoracic Organ Transplantation in Monkeys Pruner, K.B.
2018
37 4S p. S210
artikel
156 CD4 T Cells, Foreign Protein and CD22 Control Antibody Response to Non-Self Blood Group A-Antigen in A-Transgenic Mice Adam, I.
2018
37 4S p. S40
artikel
157 CD8 T Effector Memory T Cells asPredictive Biomarker of Severe Acute Rejection in Lung Transplantation Irure, J.
2018
37 4S p. S108
artikel
158 Cell Kinetics of Blood Circulating CD38+/CD138+ Plasma Cells During the Development of De Novo Donor Specific Antibody Responses Wu, G.D.
2018
37 4S p. S211
artikel
159 Cell Recovery and Regeneration in Severely Damaged Lungs on Cross-Circulation Guenthart, B.A.
2018
37 4S p. S227
artikel
160 Center Characteristics Play a Leading Role in Geographic Disparities in Access to Heart Transplantation in France Cantrelle, C.
2018
37 4S p. S436-S437
artikel
161 Center Effect on Long-term Post-transplant Survival Among Currently Active United States Heart Transplant Centers Singh, T.P.
2018
37 4S p. S49-S50
artikel
162 Center Variation in Indication and Survival after Pediatric Heart Transplantation: Analysis of a Merged UNOS-PHIS Cohort O'Connor, M.J.
2018
37 4S p. S399
artikel
163 Center Variation in Listing Parameters Among US Pediatric Heart Transplant Programs Barkoff, L.M.
2018
37 4S p. S396
artikel
164 Central VA ECMO for Severe Pulmonary Arterial Hypertension: A Novel Cannulation Strategy Tipograf, Y.
2018
37 4S p. S261-S262
artikel
165 Central versus Peripheral Cannulation of Extracorporeal Membrane Oxygenation Support during Double Lung Transplantation for Pulmonary Hypertension 2018
37 4S p. S488
artikel
166 Cerebrovascular Autoregulation is Altered During Pediatric cfVAD Support Spinner, J.A.
2018
37 4S p. S394
artikel
167 Chagas’ Disease Reactivation after Heart Transplant: Update on New Immunosuppression Era Campos, I.W.
2018
37 4S p. S156
artikel
168 Change in Heart Rate from Pre-Implant to Discharge in Destination Therapy is Associated with Mortality and Admissions in LVAD Patients- A Substudy of the ENDURANCE trial Birati, E.Y.
2018
37 4S p. S278
artikel
169 Changes in Glycemic Control and Body Mass Index in Left Ventricular Assist Device Patients with Diabetes Vest, A.R.
2018
37 4S p. S273
artikel
170 Changes in Metabolic Profiles Following Left Ventricular Assist Device Implantation Nguyen, A.
2018
37 4S p. S474-S475
artikel
171 Changes in Sexual Activity Among Patients Supported With an Implantable Left Ventricular Assist Device in Japan Kato, N.P.
2018
37 4S p. S121
artikel
172 Changing Donor Profile Over 30 Years of a Heart Transplant Program Alvarez, J.
2018
37 4S p. S351-S352
artikel
173 Changing Trends in Acceptance Criteria for Cardiac Donors: 15 Year UK Experience Page, A.
2018
37 4S p. S182-S183
artikel
174 Characteristics and Outcomes of Pediatric Patients Supported with Ventricular Assist Device - A Multi-institutional Analysis Puri, K.
2018
37 4S p. S405
artikel
175 Characteristics of Cardiopulmonary Exercise Testing in Patients with Combined Post-capillary and Pre-capillary Pulmonary Hypertension (Cpc-PH) Due to Left Heart Disease Goda, A.
2018
37 4S p. S491-S492
artikel
176 Characteristics of De Novo Donor-specific Anti-HLA Antibodies (DSAs) in Living-donor Lobar and Cadaveric Lung Transplantation Gochi, F.
2018
37 4S p. S447-S448
artikel
177 Characteristics of Patients With CTD-associated PAH Treated With Selexipag in the Real-world Setting: Interim Data From the SPHERE Registry Highland, K.B.
2018
37 4S p. S153-S154
artikel
178 Characterization of Circulating Donor Heart Specific Exosomes in Clinical Heart Transplantation Korutla, L.
2018
37 4S p. S331
artikel
179 Characterization of Endothelial Function Following Various Ischemic Durations in an Isolated Rat Heart Model of Donation After Circulatory Death Mendez Carmona, N.
2018
37 4S p. S225
artikel
180 Characterization of Vasoplegia Immediately After Heart Transplantation Esmailian, F.
2018
37 4S p. S433-S434
artikel
181 Characterizing the Airway Inflammatory Milieu in Post-Transplantation Lung Biopsies of Cystic Fibrosis Patients: A Single Institution Study of Acute Cellular Rejection McHenry, A.J.
2018
37 4S p. S305
artikel
182 Chemokine Receptor Regulation in Mechanical Circulatory Support to Predict RV Failure and Mortality is Dependent on Etiology Nayak, A.
2018
37 4S p. S86
artikel
183 Chronic Lung Allograft Dysfunction (CLAD): Donation after Circulatory Death (DCD) vs Donation After Brain Death (DBD) - The First 10 Years Snell, G.I.
2018
37 4S p. S132
artikel
184 Circulating CD9+ B Cells: Biomarker of Long-term BOS-free Survival After Lung Transplantation Brosseau, C.
2018
37 4S p. S445
artikel
185 Circulating Monocyte Subtypes Correlate with Cardiac Allograft Vasculopathy and Differ from Atherosclerotic Disease: A Tool for Monitoring? Holzhauser, L.
2018
37 4S p. S174-S175
artikel
186 Clinical and Humoral Determinants of Congestion-prone Advanced Heart Failure Phenotype Melenovsky, V.
2018
37 4S p. S311-S312
artikel
187 Clinical Characteristics of Sleep Apnea Syndrome in Heart Transplant Recipients Afzal, A.
2018
37 4S p. S334-S335
artikel
188 Clinical Classification and Prevalence of Pulmonary Hypertension in Rural Mirfakhraie, L.
2018
37 4S p. S491
artikel
189 Clinical Experience and Outcomes of HeartMate II to HeartWare Left Ventricular Assist Device Exchange: A Multicenter Experience of 24 Cases Agarwal, R.
2018
37 4S p. S367
artikel
190 Clinical Experience With Argatroban as a Therapeutic Option for LVAD Associated Device Thrombosis Ruiz-Cano, M.J.
2018
37 4S p. S364-S365
artikel
191 Clinically-unrecognized Allograft Injury is Common After Lung Transplantion Agbor-Enoh, S.
2018
37 4S p. S32-S33
artikel
192 Clinical Outcomes After Tricuspid Annuloplasty Prior to Cardiac Transplantation: A Single Center Experience Rubin, G.
2018
37 4S p. S344-S345
artikel
193 Clinical Outcomes Associated With mTORi Initiation in Adult Heart Transplant: An ISHLT Registry Analysis Duero Posada, J.G.
2018
37 4S p. S19
artikel
194 Clinical Outcomes with Heartmate 3TM Left Ventricular Assist Device as Treatment for Advanced Heart Failure: 12-Month Outcomes from the ELEVATE Registry Morshuis, M.
2018
37 4S p. S84
artikel
195 Clinical Profile of Patients with Late Stroke after Left Ventricular Assist Device Implantation Nnanabu, J.
2018
37 4S p. S60-S61
artikel
196 Clinicians’ Acceptance of Interactive Health Technologies for Self-Management among Patients with Chronic Cardiopulmonary Disorders Alrawashdeh, M.
2018
37 4S p. S37-S38
artikel
197 Club Cell Secretory Protein Replacement Therapy in a Murine Lung Transplant Model of Obliterative Bronchiolitis Konoeda, C.
2018
37 4S p. S235
artikel
198 CMV-specific T-cell Response After Lung Transplantation Rossetti, V.
2018
37 4S p. S176-S177
artikel
199 Cold and Warm Ischemia Result in Different Histological Characteristics of Reperfusion Injury After Lung Transplantation in Mice Wang, X.
2018
37 4S p. S224-S225
artikel
200 Combined Heart and Kidney Transplantation - Is There a Protective Effect Against Cardiac Allograft Vasculopathy Using Intravascular Ultrasound? Sato, T.
2018
37 4S p. S411
artikel
201 Combined Heart and Lung Transplant: Improved Survival After Implementation of Exclusion and Inclusion Criteria Cruz-Solbes, A.S.
2018
37 4S p. S425-S426
artikel
202 Combined Heart-Kidney Transplantations: İs it necessary? Konukoglu, O.
2018
37 4S p. S432
artikel
203 Comparative Infection Related Outcomes Between Recipients of an Axial Continuous-flow and an Intrapericardial Centrifugal Continuous-flow Left Ventricular Assist Device: A Single Center Experience Rind, J.
2018
37 4S p. S362
artikel
204 Comparing Outcomes and Resource Utilization Among Pediatric Heart Transplant Indications Using a Novel, Merged Data Set from the United Network for Organ Sharing and the Pediatric Health Information System (UNOS-PHIS) Databases Burstein, D.
2018
37 4S p. S401-S402
artikel
205 Comparison of Anticoagulation of Patients Who Underwent Left Ventricular Assist Device, Clinical Experience Köksel, U.
2018
37 4S p. S279
artikel
206 Comparison of Different HRQOL Measures Waitlisted Patients for Lung Transplantation Tokuno, J.
2018
37 4S p. S299-S300
artikel
207 Comparison of Extra Corporeal Membrane Oxygenation versus Cardiopulmonary Bypass Support for Lung Transplantation Mehta, V.
2018
37 4S p. S461-S462
artikel
208 Comparison of Extracorporeal Photopheresis and Thymoglobulin for the Treatment of Chronic Lung Allograft Dysfunction Martos Gisbert, N.
2018
37 4S p. S445-S446
artikel
209 Comparison of Heart Transplantation Outcomes Between Adult Congenital Heart Disease and Matched Adult Cardiac Patients in a Single Quaternary Reference Centre Kinsella, A.
2018
37 4S p. S422
artikel
210 Comparison of Hemocompatibility-Related Adverse Events in HVAD versus HeartMate II Device Mehta, P.
2018
37 4S p. S265
artikel
211 Comparison of IgG SAB and C1q Assay: A Matter of Complement Fixing or Sensitivity Murphy, C.
2018
37 4S p. S218-S219
artikel
212 Comparison of Predictors and Outcomes of Severe LV and RV Primary Graft Dysfunction in Heart Transplant Recipients Fried, J.A.
2018
37 4S p. S105
artikel
213 Comparison of Prognostic Impact Between Early-onset and Delayed-onset Cytomegalovirus Replication in Heart Transplant Recipients Rodriguez Chaverri, A.
2018
37 4S p. S354-S355
artikel
214 Comparison of Sternotomy Versus a Subcostal Approach for Exchange of HeartMate II Continuous Flow-left Ventricular Assist Device Sugiura, T.
2018
37 4S p. S271-S272
artikel
215 Comparison of Survival and Readmission Rates in Patients 65 and Older Undergoing Heart Transplantation or LVAD Implantation Imamura, T.
2018
37 4S p. S320-S321
artikel
216 Computational Fluid Dynamics (CFD) - A Reliable Basis for Therapy and Surgical VAD Strategy? Hochstuhl, J.
2018
37 4S p. S268-S269
artikel
217 Computed Tomography for Rejection Monitoring in a Murine Orthotopic Lung Transplantation Model Nakagiri, T.
2018
37 4S p. S229-S230
artikel
218 Consequences of Delayed Chest Closure During Lung Transplantation Rafiroiu, S.
2018
37 4S p. S200-S201
artikel
219 Conservation of Hearts from Brain Dead Donors with a Preservation Solution Supplemented by a Conditioned Medium from Mesenchymal Stem Cells, Improves Graft Contractility After Heart Transplantation in Rats Korkmaz-Icöz, S.
2018
37 4S p. S223
artikel
220 Conservative Treatment of Driveline Infections: A Single Centre Experience Giacomini, A.
2018
37 4S p. S362
artikel
221 Contaminated Ice. How Clean is Your Machine? Williams, C.
2018
37 4S p. S177
artikel
222 Continuous-flow Left Ventricular Assist Device Therapy in Adult Patients With Congenital Heart Disease Sugiura, T.
2018
37 4S p. S271
artikel
223 Continuous-flow LVAD Therapy: A ‘Forme-fruste’ of Diastolic Heart Failure Jain, P.
2018
37 4S p. S142-S143
artikel
224 Contribution of Individual Genes to Longitudinal Variation of Gene Expression Profile Scores DePasquale, E.C.
2018
37 4S p. S332-S333
artikel
225 Conversion from Advagraf/Prograf to Envarsus in Stable Lung Transplant Patients Murakoezy, G.
2018
37 4S p. S309
artikel
226 Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Lung Transplant Recipients: Short-Term Effects on Renal Function and Diabetic Parameters Godinas, L.
2018
37 4S p. S114-S115
artikel
227 Conversion to Extended Release Tacrolimus in Early Post Lung Transplantation Period - A Pilot Study Morlacchi, L.
2018
37 4S p. S308
artikel
228 Coronary Angiography of Potential Cardiac Donors Increases Cardiac Transplantation Rates Zuckermann, A.
2018
37 4S p. S171
artikel
229 Correlation of High Molecular Weight Von Willebrand Factor Multimer loss and Rotational Speed During Short Term Mechanical Circulatory Support Czer, L.S.
2018
37 4S p. S379-S380
artikel
230 Creatine Supplementation Attenuates Apoptosis and Proliferation of Inflammatory Cells in a Lung Transplantation Model Almeida, F.M.
2018
37 4S p. S227-S228
artikel
231 Creatinine versus Cystatin C Based Equations for Estimation of Renal Function in Left Ventricular Assist Device Patients Pinsino, A.
2018
37 4S p. S377
artikel
232 Cryotherapy of Airway Stenosis after Lung Transplant Zwintscher, N.
2018
37 4S p. S449-S450
artikel
233 CT Coronary Angiography Predicts Cardiovascular Outcomes after Heart Transplantation Zambon, E.
2018
37 4S p. S197
artikel
234 CXCR4 Inhibition Improves Donor Leukocyte Depletion During Ex Vivo Lung Perfusion Davis, R.
2018
37 4S p. S221
artikel
235 Cyclosporine Preconditioning During Ex Vivo Lung Perfusion Improves the Quality of Post Transplant Lung Grafts Noda, K.
2018
37 4S p. S222
artikel
236 Cystatin C as a Marker of Renal Injury in Pediatric Heart Transplant Recipients Goldberg, J.F.
2018
37 4S p. S395
artikel
237 Cytokine Dynamics Insights into Improved Lung Preservation Using the Organ Care System in a Porcine Transplantation Model in Comparison to the INSPIRE Trial Siemeni, T.
2018
37 4S p. S220
artikel
238 Cytomegalovirus (CMV) Infection in Pediatric Solid Organ Transplant Recipients and Role of Prophylaxis Nance, G.
2018
37 4S p. S364
artikel
239 Cytomegalovirus Donor Seropositivity Negatively Affects Mid- and Long-term Survival After Heart Transplantation Heim, C.
2018
37 4S p. S177
artikel
240 DCD Heart Retrieval Does Not Compromise Other Donor Organs: The UK Experience Page, A.
2018
37 4S p. S51
artikel
241 Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures at Incremental LVAD Speeds is a Poor Prognostic Factor Following LVAD Implantation Imamura, T.
2018
37 4S p. S485-S486
artikel
242 Dectin-1 Genotypes are Associated with Decreased CLAD-Free Survival in Lung Transplant Recipients Calabrese, D.R.
2018
37 4S p. S95
artikel
243 Defining Severe Secondary Antibody Deficiency in Heart and Lung Transplantation Carbone, J.
2018
37 4S p. S156-S157
artikel
244 De Novo Aortic Insufficiency on Left Ventricular Assist Device Support: An Analysis of the INTERMACS Registry Truby, L.K.
2018
37 4S p. S76
artikel
245 De Novo DonorSpecific Antibodies as a Risk Marker for Early Antibody Mediated Rejection Letchford, D.B.
2018
37 4S p. S325-S326
artikel
246 Depressive Symptoms Among Women and Men After Left Ventricular Assist Device Marble, J.
2018
37 4S p. S479
artikel
247 Description of Longitudinal Measurement of Donor Fraction of Cell-Free DNA Following Rejection Treatment and Correlation to Clinical Outcomes Ragalie, W.
2018
37 4S p. S402
artikel
248 Desensitization in Lung Transplant Recipients with a Positive Virtual Crossmatch Hammad, S.
2018
37 4S p. S454
artikel
249 Detecting Early Cardiac Allograft Vasculopathy Using Highly Automated 3D Coronary Optical Coherence Tomography Segmentation Analysis Pazdernik, M.
2018
37 4S p. S105-S106
artikel
250 Detection of LVAD Pump Thrombus Using Intraventricular Flow Dynamics Montes, R.
2018
37 4S p. S58
artikel
251 Development of an Ultra Compact Durable ECMO System and Evaluation in a Chronic Animal Experiment for 4 Weeks Akiyama, D.
2018
37 4S p. S262
artikel
252 Development of Exercise Capacity in LVAD Patients During Inpatient Cardiac Rehabilitation Depending on Exercise Tolerance at the Time of Admission Reiss, N.
2018
37 4S p. S144
artikel
253 Development of New Algorithms for Early Detection of Pump Thrombosis by Analysis of HeartWare LVAD Log Files Reiss, N.
2018
37 4S p. S12
artikel
254 Development of Rejection Risk Prediction Model by Routine Monitoring for De-novo Donor Specific Antibodies After Heart Transplantation WONG, K.
2018
37 4S p. S150
artikel
255 4D Flow MRI in 3D Printed Models of Aorta Grafted With a Ventricular Assist Device Allows Detailed Embolic Trajectory Analysis Amili, O.
2018
37 4S p. S59
artikel
256 Diagnostic Value of Peripheral and Bronchoalveolar Leukocyte Profile in Lung Transplant Recipients After Alemtuzumab Induction Therapy. A Single Center Experience Kováts, Z.Á.
2018
37 4S p. S452
artikel
257 Diagnostic Yield of Genetic Testing in Heart Transplant Recipients Boen, H.
2018
37 4S p. S334
artikel
258 Differences in Fibrin Metabolism Among the Species for Preclinical Large Animal Models for Cardiovascular Device Mizuno, T.
2018
37 4S p. S273
artikel
259 Differences In 24-Hour Vascular Hemodynamic Profiles Among Healthy Subjects, Heart Failure, Left Ventricular Assist Device and Heart Transplant Patients Castagna, F.
2018
37 4S p. S282-S283
artikel
260 Differential Effects of Carvedilol vs. Metoprolol on Mortality and Adverse Events in Left Ventricular Assist Devices Patients Pinsino, A.
2018
37 4S p. S484
artikel
261 Differential Effects of Levosimendan and Dobutamine on GFR in Patients With Heart Failure and Renal Impairment. A Randomized Double-blind Controlled Trial Karason, K.
2018
37 4S p. S202
artikel
262 Differential Gene Expression Profiling of Reperfusion During Ex Vivo Lung Perfusion and Lung Transplantation in Humans Wong, A.K.
2018
37 4S p. S204
artikel
263 Digital Health Monitoring of Physical and Emotional Recovery After LVAD Placement Banerjee, D.
2018
37 4S p. S288
artikel
264 Direct Acting Oral Anticoagulant Utilization, Safety and Efficacy in Heart Transplant (HT) Bellam, N.
2018
37 4S p. S112-S113
artikel
265 Discontinuation of Aspirin in Heartmate 3 Left Ventricular Assist Device Lim, S.
2018
37 4S p. S72
artikel
266 Discontinuing Amiodarone Treatment Prior to Heart Transplant May Lower Incidence of Severe Primary Graft Dysfunction Hoemann, B.
2018
37 4S p. S104-S105
artikel
267 Discordance Between Clinical and Invasive Assessment of Hemodynamics in Patients with Decompensated Heart Failure Narang, N.
2018
37 4S p. S42-S43
artikel
268 Discrepancies Between Costs and Reimbursement Values May Be Associated with Low Heart Transplants Numbers in Brazil Goldraich, L.
2018
37 4S p. S236-S237
artikel
269 Discrepancy Between Heart Rate Response and Indices of Autonomic Cardiovascular Control One Year After Heart Transplantation Nygaard, S.I.
2018
37 4S p. S421-S422
artikel
270 Distinct Phenotypic, Molecular and Immune Characteristics of Circulating Exosomes From Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome versus Stable Patients Gunasekaran, M.
2018
37 4S p. S205
artikel
271 Does a History of Malignancy Prior to Heart-transplant Increase Post-transplant Risk? Kransdorf, E.
2018
37 4S p. S421
artikel
272 Does a Redo Heart Transplant Decrease the Chance for Primary Graft Dysfunction? Levine, R.
2018
37 4S p. S349-S350
artikel
273 Does ATG Induction Prevent Donor-specific Antibodies After Heart Transplantation? Patel, J.
2018
37 4S p. S439
artikel
274 Does Center Volume Affect Failure to Rescue Rates in Lung Transplantation? A U.S. Nationwide Analysis Osho, A.A.
2018
37 4S p. S456-S457
artikel
275 Does Commuting Time to the Transplant Center Affect Compliance with Visits and Outcome after HTx in a big Metropolitan Area? Velleca, A.
2018
37 4S p. S343
artikel
276 Does Ex Vivo Perfusion Lead to More or Less Intimal Thickening in the First-year Post-Heart Transplantation? Sato, T.
2018
37 4S p. S410-S411
artikel
277 Does Gender of the Donor and Recipient Influence Survival After Lung Transplantation? Chandrashekaran, S.
2018
37 4S p. S166-S167
artikel
278 Does Increasing Experience in Implementing the Blood Pressure Management Protocol in the ENDURANCE Supplemental Trial Result in Better Outcomes? Mahr, C.
2018
37 4S p. S283
artikel
279 Does Occupation Affect Outcome Following Heart Transplantation Kao, T.
2018
37 4S p. S350-S351
artikel
280 Does the Type of Mechanical Circulatory Support as a Bridge to Heart Transplant Affect Outcome after Transplant? Esmailian, F.
2018
37 4S p. S289
artikel
281 Do Geographical, Socioeconomic, and Individual Patient Factors Influence Access to Heart Transplant? Ising, M.S.
2018
37 4S p. S340-S341
artikel
282 Do High Risk Patients Really Achieve a Survival Benefit from Heart Transplantation? A Step Towards a Cardiac Allocation Score Masetti, M.
2018
37 4S p. S172
artikel
283 Donation After Circulatory Death (DCD) Heart Transplantation in Australia: An Update of Current Practises and Outcomes Chew, H.
2018
37 4S p. S14
artikel
284 Donor Age and Ischemic Time - Implications for Efficacy of Ex-Vivo Organ Perfusion Jernryd, V.
2018
37 4S p. S170
artikel
285 Donor-derived Cell Free DNA Correlates More Closely With Intragraft mRNA Transcripts Rather Than Pathology Read Biopsies Kobashigawa, J.A.
2018
37 4S p. S198
artikel
286 Donor-Derived Cell-Free DNA in D-OAR, a Real World, Clinical Use Heart Transplant Population Kobashigawa, J.A.
2018
37 4S p. S149-S150
artikel
287 Donor-derived Cell-free DNA Investigated by Digital PCR After Targeted Pre-Amplification: A Prospective Clinical Study of Heart-transplant Patients Boehmer, J.
2018
37 4S p. S325
artikel
288 Donor Derived Cell Free DNA is Elevated With Pathogens That are Risk Factors For Chronic Lung Allograft Dysfunction Shah, P.
2018
37 4S p. S111-S112
artikel
289 Donor Heart Selection: The Outcome of Cardiac Graft Received After at Least 6 Declines by a Candidate on Medical Grounds: A Single-Center Experience Fukushima, N.
2018
37 4S p. S338
artikel
290 Donor HLA-G Single Nucleotide Polymorphisms Predict Post-lung Transplant Mortality Lazarte, J.
2018
37 4S p. S94-S95
artikel
291 Donor Lung Specific Exosome Profiles for Noninvasive Monitoring of Acute Rejection in a Rat Orthotopic Left Lung Transplant Model Habertheuer, A.
2018
37 4S p. S203-S204
artikel
292 Donor Mechanism of Death (MOD) and Interstitial Fibrin (INTFIB) as Predictors of Outcome After Heart Transplantation Hammond, E.H.
2018
37 4S p. S337-S338
artikel
293 Donor Plasma VEGF as a Biomarker for Early Graft Failure After Heart Transplantation Holmström, E.
2018
37 4S p. S103
artikel
294 Donor Pretreatment With Vasopressors: Impact on Outcome after Heart Transplantation Mehdiani, A.
2018
37 4S p. S344
artikel
295 Donor-recipient Ethnic Matching Impacts Short and Long-term Results of Heart Transplantation Peled, Y.
2018
37 4S p. S323-S324
artikel
296 Donor-recipient Factors Influencing Early Antibody Mediated Rejection in Children Molina, K.M.
2018
37 4S p. S396
artikel
297 Donor-recipient Gender-mismatches Correlate With Survival Outcome Kwakkel-van Erp, J.M.
2018
37 4S p. S250
artikel
298 Donor Right Ventricular Stroke Work Index (RVSWI) is a Poor Predictor of Primary Graft Dysfunction (PGD) After Heart Transplantation Das De, S.
2018
37 4S p. S349
artikel
299 Donor Simvastatin Treatment Alters Protein Expression in the Recipient after Heart Transplantation Lukac, J.
2018
37 4S p. S169-S170
artikel
300 Donor Simvastatin Treatment Alters the Gene Expression Profile of Human Cardiac Allografts During Ischemia and Reperfusion Krebs, R.
2018
37 4S p. S346-S347
artikel
301 Donor Specific Antibodies in Heart Transplantation: Do Clinicians Need to do Something Always? Moayedi, Y.
2018
37 4S p. S107
artikel
302 Donor to Recipient Predicted Total Lung Capacity Ratio Matching Predicts Survival after Lung Transplantation in Pre-Adolescent Patients Fraser, C.D.
2018
37 4S p. S97
artikel
303 Don’t Pass the Peanuts: Donor-Derived Nut Allergy in Lung Transplant Bag, R.
2018
37 4S p. S247
artikel
304 Double Lungtransplantation In Patients with End-Stage Pulmonary Arterial Hypertension or End-Stage Inoperable Chronic Thromboembolic Pulmonary Hypertension Rinaldi, A.
2018
37 4S p. S494
artikel
305 Double-Lung versus Heart-Lung Transplantation for Pulmonary Hypertension - A Single-Center Experience Brouckaert, J.
2018
37 4S p. S492-S493
artikel
306 Double-Negative αβ T cells: A Novel Player in Lung Ischemic-Reperfusion Injury Hsu, J.
2018
37 4S p. S221
artikel
307 2D Speckle Tracking to Assess Left Ventricular Function in a Model of Ex Vivo Heart Perfusion Ruggeri, G.
2018
37 4S p. S228
artikel
308 Dual Ex-vivo Lung Perfusion Using Human Lungs Noda, K.
2018
37 4S p. S222
artikel
309 Duchenne Muscular Dystrophy-Related Acute Heart Failure: Multicenter Study of Hospitalizations and Outcomes Deshpande, S.R.
2018
37 4S p. S388-S389
artikel
310 Durability of Aortic Valve Repair with Park Stitch in Patients with Continuous Flow LVADS Konik, E.
2018
37 4S p. S480-S481
artikel
311 Durability of Medical Therapy for Heartware LVAD Thrombosis Wald, J.W.
2018
37 4S p. S371
artikel
312 Duration of ECMO Support Predicts Survival in Transplant Patients Grijalva, J.
2018
37 4S p. S397
artikel
313 Dynamic Myocardial Response to Exercise in Children with Isolated Non-compaction of the Left Ventricular Myocardium Chen, C.
2018
37 4S p. S389
artikel
314 Dynamic Phenomapping and HLA Class I and II Antibodies for Heart Transplant Outcomes Bakir, M.
2018
37 4S p. S416-S417
artikel
315 Dynamics of Transient Populations of the Human Respiratory Virome After Lung Transplantation Mitchell, A.B.
2018
37 4S p. S38-S39
artikel
316 Earlier Cardiac Allograft Vasculopathy and Graft Failure in Pediatric Heart Transplant Recipients After Rejection with Severe Hemodynamic Compromise Kleinmahon, J.A.
2018
37 4S p. S191-S192
artikel
317 Early Acute Cellular Rejection in Lung Transplant Recipients is Associated with Greater Variation in the Lung Allograft Microbiome Iasella, C.J.
2018
37 4S p. S441-S442
artikel
318 Early and Continued Improvement in Cognition in Response to Left Ventricular Assist Device Implantation Lee, C.S.
2018
37 4S p. S120-S121
artikel
319 Early and Late Outcomes of Subcostal Exchange of HeartMate II Left Ventricular Assist Device: A Word of Caution Yu, S.N.
2018
37 4S p. S100
artikel
320 Early Changes in Donor Fraction Cell-free DNA in Newly Transplanted Pediatric Heart Transplant Patients Kindell, S.
2018
37 4S p. S400
artikel
321 Early Detection of Chronic Lung Allograft Dysfunction After Bilateral Living Donor Lobar Lung Transplantation by Computed Tomographic Scanning Scoring Method Niman, E.
2018
37 4S p. S444
artikel
322 Early Elevated Plasma Free Hemoglobin Predicts Occurrence of Thromboembolic Stroke during Venoarterial Extracorporeal Membrane Oxygenation Support Saeed, O.
2018
37 4S p. S29-S30
artikel
323 Early Experience of Durable Left Ventricular Assist Devices: Do We Need Bridge to Transplant Strategy in Korea? Lee, J.
2018
37 4S p. S263-S264
artikel
324 Early Experience With the Use of Hepatitis C Antibody-positive, Nucleic Acid Testing-negative Donors in Lung Transplantation Mulvihill, M.S.
2018
37 4S p. S77
artikel
325 Early Implantation of Ventricular Assisted Devices (VADs) in Failing Single Ventricle Physiology Patients Can Lead to Better Outcomes in Pediatric Heart Transplantation Shih, R.
2018
37 4S p. S408
artikel
326 Early Outcomes from DCD Heart Transplantation: A Single Centre Experience Page, A.
2018
37 4S p. S13-S14
artikel
327 Early Outcomes Using Hepatitis C-Exposed Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments Schlendorf, K.
2018
37 4S p. S341
artikel
328 Early Postoperative Heparinization is Crucial for Prevention of Cerebral Vascular Accident in Patients with HeartMate II Matsumoto, Y.
2018
37 4S p. S369
artikel
329 Early Postoperative Organ Function Recovery Score and Long-term Survival in Advanced Heart Failure Patients Undergoing Mechanical Circulatory Support Masukawa, L.M.
2018
37 4S p. S466
artikel
330 Early Rhinovirus Infection After Lung Transplantation - Simply the Innocent Bystander? Thaniyavarn, T.
2018
37 4S p. S358
artikel
331 Early Survival after Lung Transplantation is Improving in Patients over Age 65 Iyengar, A.
2018
37 4S p. S240
artikel
332 Echocardiographic Analysis and Outcome in Patients With Functional Mitral Regurgitation Receiving Mitraclip Therapy Reichart, D.
2018
37 4S p. S201
artikel
333 Echocardiographic Evaluation of Right Ventricular Function during Ex Vivo Heart Perfusion Ruggeri, G.
2018
37 4S p. S383-S384
artikel
334 Echocardiographic Recovery of Function and Survival in Patients with Significant Cardiac Dysfunction from Anthracycline Induced Cardiomyopathy Khan, A.M.
2018
37 4S p. S390-S391
artikel
335 Echocardiography Predicts the Outcome in Pulmonary Arterial Hypertension Patients Treted With Parenteral Prostanoids Badagliacca, R.
2018
37 4S p. S206
artikel
336 Effect of ABCC2 Polymorphisms on Tacrolimus Disposition in Heart Transplant Recipients Oreschak, K.
2018
37 4S p. S115
artikel
337 Effect of Aortic Cross-clamping During Left Ventricular Assist Device Implantation: A Single Institutional 13-year Experience Over 500 Implantations Kawabori, M.
2018
37 4S p. S481
artikel
338 Effect of Cardiac Rehabilitation on Muscle Mass, Muscle Strength, and Exercise Tolerance in Patients with Heart Failure Kim, K.
2018
37 4S p. S69
artikel
339 Effect of Different Treatment Modalities for End-stage Renal Disease After Heart Transplantation Roest, S.
2018
37 4S p. S423
artikel
340 Effect of Donor Renal Function on Heart Transplant Outcomes Panhwar, M.S.
2018
37 4S p. S428
artikel
341 Effect of Erythropoietin on Cardiac Allograft Survival in Non-Human Primates O, J.
2018
37 4S p. S217
artikel
342 Effect of Everolimus and CNI Reduction on Rejection, CLAD, and Death in Thoracic Transplant Recipients Cartus, R.A.
2018
37 4S p. S91
artikel
343 Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated With a Continuous Flow Left Ventricular Assist Device: A Multicentre Study Mirza, K.K.
2018
37 4S p. S143-S144
artikel
344 Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients - 1 Year Follow Up (The HITTS Study) Nytrøen, K.
2018
37 4S p. S196
artikel
345 Effect of Lung Protective Ventilation on Lung Procurement in a Real-life Setting legeai, c.
2018
37 4S p. S249
artikel
346 Effect of Marijuana Exposure on Calcineruin Inhibitor Dose to Trough Ratios in Heart Transplant Recipients Shakowski, C.
2018
37 4S p. S90
artikel
347 Effect of Rabbit Anti-Thymocyte Globulin Induction Therapy on the Incidence of Acute Cellular Rejection and Infection Complications After Lung Transplantation Havlin, J.
2018
37 4S p. S454-S455
artikel
348 Effects of Percutaneous LVAD Support on Right Ventricular Load and Adaptation Acutely and Over Time Yourshaw, J.P.
2018
37 4S p. S47
artikel
349 Effects of Right Ventricle Optimization on Post-Operative Outcomes: A Retrospective Comparison Sagebin, F.
2018
37 4S p. S281
artikel
350 Effects of Short and Long Term Cold Static Preservation Followed by Normothermic Ex Vivo Lung Perfusion in a Porcine Model Olbertz, C.
2018
37 4S p. S224
artikel
351 Efficacy and Safety of Trans-bronchial Cryo in Comparison With Forceps Biopsy in Lung Allograft Recipients: Analysis of 402 Procedures Gershman, E.
2018
37 4S p. S199
artikel
352 Efficacy of Ribavirin in the Treatment of Respiratory Syncytial Virus Infections in Lung-Transplant Recipients Voet, D.
2018
37 4S p. S361
artikel
353 Elamipretide Normalizes Protein and mRNA Expression Levels of Mitofilin in Left Ventricular Myocardium of Dogs with Advanced Heart Failure Sabbah, H.N.
2018
37 4S p. S219
artikel
354 Elective and Emergency Heart Transplantation: Costs Comparison in a Single Center Farrero Torres, M.
2018
37 4S p. S236
artikel
355 Electrocardiogram-synchronized Rotational Speed Modulation System Can Reduce the Recirculation Due to Aortic Insufficiency in LVAD Support Iizuka, K.
2018
37 4S p. S266
artikel
356 Elevated Donor-Derived Cell-Free DNA (ddcfDNA) as an Early Risk Factor for the Development and Persistence of De Novo Donor Specific HLA Antibody Jackson, A.M.
2018
37 4S p. S16-S17
artikel
357 Elevated Panel Reactive Antibodies in Patients Bridged to Heart Transplantation with Ventricular Assist Devices Iyengar, A.
2018
37 4S p. S66
artikel
358 Elevated Pre-transplant Left Ventricular End Diastolic Pressure is Associated With Increased Risk of Primary Graft Dysfunction in Lung Transplant Recipients Li, D.
2018
37 4S p. S458
artikel
359 Elevated Red Cell Distribution Width is Associated with Increased Incidence of Late Allograft Rejection after Heart Transplantation Poglajen, G.
2018
37 4S p. S326
artikel
360 Emphysema Induces Lung-Specific Autoantibodies that Exacerbate Ischemia Reperfusion Injury Post-Lung Transplantation Patel, K.J.
2018
37 4S p. S82-S83
artikel
361 Endocrine Profile of Heart Transplant Recipients in an Early Post-transplant Period Jensterle, M.
2018
37 4S p. S335
artikel
362 Endomyocardial Biopsy - A Source of Heartache Zangwill, S.
2018
37 4S p. S387-S388
artikel
363 Endothelial to Mesenchymal Transition (EndMT) Occurs in Lungs Secondary to Heart Failure in a Non Ischemic Cardiomyopathy Mouse Model Hussain, F.
2018
37 4S p. S52-S53
artikel
364 Endothelin-1 Derived from the Pulmonary Endarterectomy Specimen Could Play a Major Role in Pathogenesis of Chronic Thromboembolic Pulmonary Hypertension Zhao, Y.
2018
37 4S p. S53
artikel
365 Enhanced Thrombin Formation in Patients with Implanted LVADs Experiencing GI and Other Bleeding: Insights from the Multi-center PREVENT Study Jeske, W.P.
2018
37 4S p. S160
artikel
366 Eosinophils on Transbronchial Biopsies Are Predictive of Reduced Survival After Lung Transplantation Darley, D.R.
2018
37 4S p. S111
artikel
367 Epidemiology and Risk Factors of Post Operative Pneumonias After Heart Transplantation Vidal, C.
2018
37 4S p. S357-S358
artikel
368 Epithelial Cell Death Markers in Bronchoalveolar Lavage Correlate with Chronic Lung Allograft Dysfunction Phenotypes Levy, L.
2018
37 4S p. S215
artikel
369 Epstein-Barr Virus Mismatch (Donor+/Recipient-): Is Cancer the Only Risk? Patel, J.
2018
37 4S p. S355
artikel
370 Establishing a Lung Transplant Program in a Resource Constrained Setting Rahulan, V.
2018
37 4S p. S255
artikel
371 Establishing Chronic Stable Heart Failure in Ovine Model; is It Feasible? Torregroza, C.
2018
37 4S p. S234
artikel
372 Estimation of Central Venous Pressure by Pacemaker Lead Impedances in LVAD Patients Imamura, T.
2018
37 4S p. S486
artikel
373 Estimation of Mean Arterial Pressure in HeartMate II Patients Using Doppler Blood Pressure and Pump Speed Pinsino, A.
2018
37 4S p. S30
artikel
374 Evaluating the Impact of Gene Expression Profiling on Tricuspid Regurgitation in Cardiac Transplant Patients Mehta, N.
2018
37 4S p. S336-S337
artikel
375 Evaluation of HeartWare HVAD Appearance on Serial Chest Radiographs: Pump Position and Migration Influence Adverse Outcomes Pietras, C.M.
2018
37 4S p. S144-S145
artikel
376 Evaluation of Prophylactic Valganciclovir for Cytomegalovirus (CMV) in Pediatric Heart Transplant Recipients Nance, G.
2018
37 4S p. S389
artikel
377 Evaluation of the CHADS2, CHA2DS2-VASc, and R2CHADS2 Risk Assessment Scores in Continuous Flow LVADs Santiago, A.
2018
37 4S p. S130
artikel
378 Evaluation of the Prognostic Factor and the Treatment Efficacy of Inhaled Iloprost in Patients with Group 3 Pulmonary Hypertension Su, P.
2018
37 4S p. S493
artikel
379 Evaluation of the Urgency Based Lung Allocation System in Korea Using the Lung Allocation Score (LAS) System Yu, W.
2018
37 4S p. S238
artikel
380 Evidence for Subclinical, Progressive Outflow Graft Stenosis in Patients With Heartware HVAD Jain, P.
2018
37 4S p. S146-S147
artikel
381 Evidence of Maturation Stoppage of Peripheral B-cells Induced by Immunosuppression of Recall Alloantibody Responses Wu, G.D.
2018
37 4S p. S211
artikel
382 Exercise Capacity and Functional Performance in Patients With an HVAD Left Ventricular Assist Device (LVAD): Development 6 Month After Discharge From Cardiac Rehabilitation Schmidt, T.
2018
37 4S p. S286-S287
artikel
383 Exercise Training in Pediatric Ventricular Assist Device Recipients Burstein, D.S.
2018
37 4S p. S402
artikel
384 Exosomes With Lung Self-antigens, Kα1Tubulin and Collagen V, as Biomarker for Bronchiolitis Obliterans Syndrome Following Human Lung Transplantation Mohanakumar, T.
2018
37 4S p. S34
artikel
385 Experience of Using mTOR Inhibitor in Lung Transplant at Recipients With Lymphangioleiomyomatosis Kurosaki, T.
2018
37 4S p. S455-S456
artikel
386 Exploring the Relationship Between BMI and Obesogenic Factors Including Nutritional Knowledge, Intake, Psychological Behaviours, Physical Activity and Quality of Life in a Post Heart Transplant Population: A Cross Sectional Study Patel, R.
2018
37 4S p. S297
artikel
387 Ex-situ Intra-vascular Ultrasound (IVUS) May Allow Safe Access to Extended Criteria DCD Heart Donors Messer, S.
2018
37 4S p. S429-S430
artikel
388 Extended Clinical Normothermic Ex-Vivo Portable Lung Preservation (>8 Hours) is Feasible and Safe Ceulemans, L.J.
2018
37 4S p. S243
artikel
389 Extracorporeal Life Support After Pulmonary Thromboendarterectomy: Single Institutions Outcome Higgins, J.R.
2018
37 4S p. S487-S488
artikel
390 Extracorporeal Life Support in Patients with Primary Cardiogenic Shock: Predictors of Recovery and Survival Tarzia, V.
2018
37 4S p. S265-S266
artikel
391 Extracorporeal Membrane Oxygenation as a Bridge to Heart Transplant versus Left Ventricular Assist Device: Analysis of a Multicenter, Nationwide Database Shah, Z.
2018
37 4S p. S28
artikel
392 Extra-Corporeal Membrane Oxygenation (ECMO) as a Bridge to A Long-Term, Implantable Left Ventricular Assist Device Lamba, H.
2018
37 4S p. S43-S44
artikel
393 Extra-corporeal Membrane Oxygenation (ECMO) as a Bridge to Lung Transplantation: Outcomes in the Current Era Lari, S.M.
2018
37 4S p. S242
artikel
394 Extra Corporeal Membrane Oxygenation (ECMO) for Primary Graft Dysfunction Following Heart Transplantation: A Single Centre Experience Mehta, V.
2018
37 4S p. S347-S348
artikel
395 Extracorporeal Membrane Oxygenation for Cardiogenic Shock: National trends in the United States 2008-2012 Arora, A.
2018
37 4S p. S48
artikel
396 Extracorporeal Membrane Oxygenation for Treatment of Primary Graft Dysfunction in Heart Transplant: Comparison of Central and Peripheral Cannulation Boeken, U.
2018
37 4S p. S348-S349
artikel
397 Extracorporeal Membrane Oxygenation to Transplant Survival: Past, Present and Future Kamath, M.Y.
2018
37 4S p. S29
artikel
398 Extracorporeal Photopheresis as Treatment Option of Chronic Lung Allograft Dysfunction. Is ECP the Therapy of the Future? Benazzo, A.
2018
37 4S p. S110
artikel
399 Extracorporeal Photophoresis Promotes Alveolar Macrophage Production of Anti-fibrogenic Mediators and Prevents Airway Obliteration in a Mouse Lung Allograft Model Liu, Z.
2018
37 4S p. S208
artikel
400 Extremes of Age Decrease Survival After Lung Transplant Lehr, C.J.
2018
37 4S p. S183-S184
artikel
401 Ex vivo Effects of a Pediatric Extracorporeal Membrane Oxygenation (ECMO) Circuit on the Sequestration of Mycophenolate Mofetil and Tacrolimus Heith, C.S.
2018
37 4S p. S407
artikel
402 Ex-Vivo Lung Perfusion in Donation After Circulatory Death Lung Transplantation Increases Donor Utilization: Analysis of the NOVEL Extension Trial Whitson, B.A.
2018
37 4S p. S147-S148
artikel
403 Ex vivo Lung Perfusion Using the Portable OCS Maintains Endothelial Integrity in the Context of Reduced Severe PGD Rates Wiegmann, B.
2018
37 4S p. S204-S205
artikel
404 Ex-vivo Lung Perfusion - 10 Year Follow-up of the First Performed Double LTX With Marginal Donor Lungs Evaluated Using EVLP Fakhro, M.
2018
37 4S p. S149
artikel
405 Facilitating Donation After Circulatory Death in Heart Transplantation: Effects of Cardioprotective Reperfusion Strategies on Mitochondria Sanz, M.N.
2018
37 4S p. S225
artikel
406 Factors Influencing Heart Rate Control After Heart Transplantation Christensen, A.H.
2018
37 4S p. S352
artikel
407 Factors Influencing Outcomes from Listing for Lung Transplantation in the UK Kourliouros, A.
2018
37 4S p. S184-S185
artikel
408 Factor VIIa Does not Contribute to Mortality in Lung Transplant Recipients after Adjustment for Packed Red Blood Cell Transfusions Huddleston, S.J.
2018
37 4S p. S257
artikel
409 Failure to Improve Renal Function Following VAD Placement Predicts Renal Injury and Chronic Kidney Disease Following Cardiac Transplant Hollander, S.A.
2018
37 4S p. S117-S118
artikel
410 Family Participation in Daily ECMO Rounds Stahovich, M.
2018
37 4S p. S189
artikel
411 Favorable Outcomes With Ventricular Assist Device Exchange for Refractory Infections Carroll, M.M.
2018
37 4S p. S363-S364
artikel
412 Feasibility and Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock: Preliminary Results Taleb, I.
2018
37 4S p. S316
artikel
413 Feasibility, Efficacy and Safety of Fibrinogen Guided Very Low Dose Multi-Day Thrombolytics in the Management of LVAD Thrombosis Cruz-Solbes, A.S.
2018
37 4S p. S57
artikel
414 Feasibility of Avoiding Higher Risk Epitope and Allele HLA Mismatch to Reduce de novo Donor Specific Antibody (dnDSA) in Lung Transplantation Zamel, R.
2018
37 4S p. S17-S18
artikel
415 Fibroblast Growth Factor 23 is a Strong Predictor of Right Ventricular Failure and Postoperative Complications After LVAD Implantation: A Pilot Study Zayat, R.
2018
37 4S p. S365-S366
artikel
416 Fifty Years of Pediatric Heart Transplantation - The First Successful Case and Results of the Early Era Kirk, C.R.
2018
37 4S p. S400-S401
artikel
417 Financial Impact of One Year of Advanced Heart Failure Therapies to a Hospital System Vohra, A.S.
2018
37 4S p. S188-S189
artikel
418 Flow Performance of the CorWave LVAD Membrane Wave Pump Botterbusch, C.N.
2018
37 4S p. S259
artikel
419 Fluid Challenge During Right Heart Catheterization: An Experience From a Tertiary Pulmonary Hypertension Referral Centre Moghaddam, N.
2018
37 4S p. S491
artikel
420 Forgotten Women: Use of Female Donors and Survival Outcomes Baran, D.A.
2018
37 4S p. S137
artikel
421 Frailty as a Predictor of Prognostic Outcomes in Patients with Interstitial Lung Disease Referred for Lung Transplantation Montgomery, E.
2018
37 4S p. S165
artikel
422 Frailty Assessment in Lung Transplant Candidates: The Use of the Short Performance Physical Battery Carswell, A.L.
2018
37 4S p. S120
artikel
423 Frailty: Does it Predict Length of Stay in Hospital Post Lung Transplant Jackson, F.
2018
37 4S p. S121-S122
artikel
424 Frailty Predicts Mortality After Heart Transplantation Offen, S.
2018
37 4S p. S49
artikel
425 Frailty Screening in Advanced Heart Failure Patients Provided Multidimensional Prognostic Information and Disease Management Strategies Fan, K.
2018
37 4S p. S70
artikel
426 Frequency of Monocyte Subtypes and TLR4 Expression Correlate with Clinical Outcomes After Mechanical Circulatory Device Implantation Schaenman, J.M.
2018
37 4S p. S213
artikel
427 Functional Decline of the Ex Vivo PerfusedHeart is Not Due to Cell Death Hatami, S.
2018
37 4S p. S226
artikel
428 Further Improvement of Exercise Capacity One Year After Implantation of a Cf- Left Ventricular Assist Device Felix, S.
2018
37 4S p. S129
artikel
429 GALA-based SOM (Somah) Protects Coronary Endothelial and Vasomotor Function Following Ex Vivo Heart Perfusion Ribeiro, R.V.
2018
37 4S p. S222
artikel
430 Gender and Diastolic Dysfunction May be the Driver of Failure of Myocardial Recovery Following LVAD Implantation Stawiarski, K.
2018
37 4S p. S311
artikel
431 Gender Differences in Cardiac Reverse Remodeling in Mechanically Unloaded Hearts Westhofen, S.
2018
37 4S p. S385
artikel
432 Gender Mismatch in NonVAD Patients Doesn’t Negatively Affect Heart Transplant Survival Itoda, Y.
2018
37 4S p. S50
artikel
433 Gender Mismatch with Female Donor Hearts to Male Recipients: A Single Center Analysis Rajagopalan, N.
2018
37 4S p. S339-S340
artikel
434 Gene Expression Profiling for Cardiac Transplant Recipients: Results from the Outcomes AlloMap® Registry Hall, S.A.
2018
37 4S p. S332
artikel
435 Gene Expression Profiling in Murine Orthotopic Lung Transplantation Model of Chronic Lung Allograft Dysfunction (CLAD) Hata, A.
2018
37 4S p. S203
artikel
436 Genetic Epidemiologyof Ventricular Tachycardia in Patients with Cardiomyopathy in Kazakhstan: ATargeted Sequencing Study Bekbossynova, M.
2018
37 4S p. S322
artikel
437 Geographic Disparities in Donor Lung Availability Impact Waitlist Outcomes in Lung Transplant Candidates: A Retrospective Cohort Study Benvenuto, L.J.
2018
37 4S p. S167
artikel
438 Geographic Variation in the Treatment of US Heart Transplant Candidates Parker, W.
2018
37 4S p. S181
artikel
439 Giant-cell Myocarditis: A Case Series from the Perspective of a United Kingdom Cardiac Transplantation Centre Okonkwo, N.
2018
37 4S p. S419
artikel
440 Giant Cell Myocarditis Patients Undergoing Heart Transplantation Have High Rates of Rejection, Infection and Cardiac Allograft Vasculopathy: Case Series Lumish, H.S.
2018
37 4S p. S422-S423
artikel
441 Glycosylated Hemoglobin (HbA1c) as a Predictor of Adverse Outcomes in Left Ventricular Assist Device (LVAD) Patients Einarson, E.
2018
37 4S p. S282
artikel
442 Good or Bad: CMS Flagging is Associated with Fewer Transplants Performed by Repeat Offenders Beller, J.P.
2018
37 4S p. S188
artikel
443 Gut Microbiome-Generated Metabolite Trimethylamine-N-Oxide is Reduced After Heart Transplantation and Continuous Flow Left Ventricular Assist Device Therapy in Advanced Heart Failure Patients Yuzefpolskaya, M.
2018
37 4S p. S235
artikel
444 Health Literacy Among Lung Transplant Recipients 1-5 Years Post Transplantation Forsberg, A.
2018
37 4S p. S300
artikel
445 Heart and Heart-Kidney Transplantation from Hepatitis C Virus (HCV) Positive Donors into HCV-Negative Recipients Aslam, S.
2018
37 4S p. S76-S77
artikel
446 HeartEn Bloc Thymus Cotransplantation in NHPs Controls Cellular but not Humoral Alloreactivity Sommer, J.O.W.
2018
37 4S p. S23-S24
artikel
447 Heart Failure Clinicians Want to Revive the REVIVE-IT Study Following the Results of the MOMENTUM 3 and ENDURANCE Supplement Trials Sayer, G.
2018
37 4S p. S466
artikel
448 Heart Failure in Rheumatoid Arthritis Patients: Trend of Admissions and Use of Advanced Heart Failure Therapies Blumer, V.
2018
37 4S p. S293
artikel
449 Heartmate 3 versus Heartmate 2: Is New Always Better ? Ozturk, P.
2018
37 4S p. S272-S273
artikel
450 Heart Preservation With the Organ Care System in Germany - Revival in High Risk Recipients Ius, F.
2018
37 4S p. S410
artikel
451 Heart Transplantation from Donors with Low Left Ventricle Systolic Function Poptsov, V.N.
2018
37 4S p. S344
artikel
452 Heart Transplantation in Infants and Children: The Thirty-Year Loma Linda University Experience Bock, M.J.
2018
37 4S p. S190
artikel
453 Heart Transplantation in Patients with Active Prostate Cancer; Are We Denying a Life Saving Therapy Due to an Indolent Tumor? Raikhelkar, J.
2018
37 4S p. S50
artikel
454 Heart Transplantation Using the Normothermic Ex-Vivo Perfusion Device Organ Care System for Donor Heart Preservation - Long-term Outcomes Fujita, B.
2018
37 4S p. S411
artikel
455 Heart Transplant Outcomes in Patients Listed for Kidney Transplant Kamath, M.Y.
2018
37 4S p. S93
artikel
456 Heart Transplant Tolerance Induction in Mice: Understanding the Complex Interplay Between Tolerizing Cells and Host Immune System by Systematic Depletion of Effector Cells Bascom, R.A.
2018
37 4S p. S126-S127
artikel
457 HeartWare HVAD Log Files Provide Insight into Patient Behavior and Predicts Adverse Events Kiehl, K.L.
2018
37 4S p. S281-S282
artikel
458 Hemi-Diaphragm Paralysis and Diaphragm Plication After Lung Transplant Diaz-Guttierez, I.
2018
37 4S p. S257
artikel
459 Hemocompatibility of an Ambulatory Counterpulsation Circulatory Assist System Jeevanandam, V.
2018
37 4S p. S58
artikel
460 Hemocompatibility Related Adverse Events and Competitive Outcomes of Different Generation of Left Ventricular Assist Devices Loforte, A.
2018
37 4S p. S370
artikel
461 Hemodynamic and Functional Analysis of Human DCD Hearts Undergoing Normothermic Ex Vivo Perfusion Sommer, W.
2018
37 4S p. S410
artikel
462 Hemodynamic Determinants of Decline in Renal Function During Left Ventricular Assist Device Support Pinsino, A.
2018
37 4S p. S376-S377
artikel
463 Hemodynamic Effects of an Intra-aortic Micro-axial Flow Pump in a Swine Model of Ischemic Heart Failure Annamalai, S.K.
2018
37 4S p. S262-S263
artikel
464 Hemodynamic Markers of Predominant Right Ventricular Dysfunction are Associated with Paradoxical Decreased Cell-Mediated Immunity in Patients with Advanced Heart Failure Alvarez, P.
2018
37 4S p. S186-S187
artikel
465 Hemodynamic Response to Continuous-flow Left Ventricular Assist Device Ramp Test and Volume Loading Predicts Successful Weaning from the Device Support Saito, S.
2018
37 4S p. S179
artikel
466 Hepatitis C Virus Antibody Formation After LVAD Implantation Sims, D.B.
2018
37 4S p. S136
artikel
467 Hepatitis E Virus Infection in Lung Transplant Recipients Ambrocio, G.
2018
37 4S p. S77-S78
artikel
468 Heterotopic Cardiac Transplantation: Time for Another Look? Letsou, G.V.
2018
37 4S p. S348
artikel
469 High Body Mass Index is a Risk Factor for Acute Cellular Rejection in Lung Transplant Recipients Nunes, F.S.
2018
37 4S p. S440-S441
artikel
470 High Burden of Diarrhea and Abdominal Pain After Pediatric Heart Transplantation Spinner, J.A.
2018
37 4S p. S394-S395
artikel
471 High Circulating CD4+CD25hiFOXP3+ T Cell Subpopulation Early After Lung Transplantation is Associated With Development of Bronchiolitis Obliterans Syndrome Durand, M.
2018
37 4S p. S444
artikel
472 Higher Age and Lower BMI Are Stronger Predictors of Mortality For Females Than Males on VA ECMO Leacche, M.
2018
37 4S p. S45-S46
artikel
473 Higher FiO2 and Elevated Cell-Free Hemoglobin Augment the Risk of Primary Graft Dysfunction Through Direct Effects on Lung Vascular Permeability Shaver, C.M.
2018
37 4S p. S123
artikel
474 Higher Frequency of Surveillance Endomyocardial Biopsies not Associated with Improved Survival After Heart Transplantation; A 10-Year, Single-Center Experience in Thailand Sinphurmsukskul, S.
2018
37 4S p. S333-S334
artikel
475 Higher Soluble Thrombomodulin and Angiogenic Markers in LVAD Supported Patients Associate with Arteriovenous Malformation and Non-Surgical Bleeding Muthiah, K.
2018
37 4S p. S159-S160
artikel
476 High Frequencies of Regulatory T Cells Are Associated with Less Chronic Lung Allograft Dysfunction in Cystic Fibrosis Patients After Combined Lung and Liver Transplantation Salman, J.
2018
37 4S p. S33-S34
artikel
477 High-Intensity Interval Training Improves Exercise Performance in Patients with LVAD Alvarez Villela, M.
2018
37 4S p. S119
artikel
478 Highly Accurate Continuous Blood Pressure Measurement in LVAD Patients with a Non-Invasive, Non-Oscillometric Wearable Device: A Pilot Study Sayer, G.
2018
37 4S p. S44
artikel
479 Highly Sensitized Heart Transplant Recipients Have Similar Outcomes Irrespective of Pre-transplant Ventricular Assist Device Implantation Fraser, C.D.
2018
37 4S p. S70
artikel
480 High Prevalence of BK Virus in Heart Transplant Patients and Effect on Outcomes Nguyen, A.
2018
37 4S p. S354
artikel
481 High Thromboembolic Event Rate in Patients Supported With an Impella CP Device With an Anti-Xa Level of Less Than 0.1 u/mL Batra, S.
2018
37 4S p. S59
artikel
482 High Variability in Tacrolimus Trough Levels is Associated With Rejections After Heart Transplantation Gueta, I.
2018
37 4S p. S419
artikel
483 High Volume Intraoperative Transfusion is Associated with Decreased Early Survival in Recipients of Ventricular Assist Devices Forest, S.J.
2018
37 4S p. S276
artikel
484 Histologic and Molecular Microscope Determinants of Graft Survival in the INTERHEART Study: The Greater Importance of T Cell-mediated Rejection vs. Antibody-mediated Rejection in Graft Loss Reeve, J.
2018
37 4S p. S303
artikel
485 HLA Donor Specific Antibody and HLA Antigen Bias are Independent Risk Factors for Chronic Lung Allograft Dysfunction Roberts, T.K.
2018
37 4S p. S443
artikel
486 Hospital Costs for Pediatric Patients With Temporary Ventricular Assist Devices: A Multicenter Study From the Pediatric Interagency Registry for Mechanically Assisted Circulatory Support (Pedimacs) and the Pediatric Health Information System (PHIS) Rossano, J.W.
2018
37 4S p. S404-S405
artikel
487 Hospital Pathways Within One Year Before Cardiac Transplantation: A French Nationwide Study Cantrelle, C.
2018
37 4S p. S314
artikel
488 Human Immunodeficiency Virus (HIV), Heart Transplantation And Mechanical Circulatory Support (MCS): Where Do We Stand? Madan, S.
2018
37 4S p. S106
artikel
489 Human Leukocyte Antigen Allosensitization in Patients Bridged to Lung Transplantation with Extracorporeal Membrane Oxygenation Courtwright, A.
2018
37 4S p. S89
artikel
490 Human Leukocyte Compatibility and Heart Transplant Survival Using a Validated Matching Algorithm Rivard, A.
2018
37 4S p. S183
artikel
491 Human Thrombomodulin Expression Confers Prolonged Graft Survival over Costimulation Blockade Alone in a Pig-to-Baboon Heterotopic Cardiac Xenotransplant Model DiChiacchio, L.
2018
37 4S p. S23
artikel
492 HVAD Thrombosis - Searching for the Source Kaufmann, F.
2018
37 4S p. S145-S146
artikel
493 Hyaluronan in Acute Rejection After Lung Transplantation Todd, J.L.
2018
37 4S p. S441
artikel
494 Hybrid Stage 1 Palliation as a Bridge to Cardiac Transplantation in Patients With High Risk Single Ventricle Physiology Morray, B.H.
2018
37 4S p. S403
artikel
495 Hyperlipidemia Impairs Autophagy in Chronic Heart Failure Marek-Iannucci, S.
2018
37 4S p. S233
artikel
496 IABP as a Bridge to Transplantation: Can we Identify Who May Benefit From a LVAD? Guha, A.
2018
37 4S p. S267
artikel
497 Ideal Body Weight May Be A Better Comparative Variable than Actual Body Weight for Donor-Recipient Matching in Orthotopic Heart Transplantation Hoemann, B.
2018
37 4S p. S437
artikel
498 Identification of Leukocyte Subpopulations as Potential Biomarkers of Long-term Survival With Normal Allograft Function After Lung Transplantation Mendoza-Valderrey, A.
2018
37 4S p. S212
artikel
499 Identifying Ambulatory Advanced Heart Failure Patients at High Risk for Death, LVAD or Transplant at 1-year: How Did the REVIVAL Eligibility Criteria Perform? Aaronson, K.D.
2018
37 4S p. S195-S196
artikel
500 Identifying Appropriate Durable VAD Candidates in Patients with Veno-Arterial Extracorporeal Membrane Oxygenation: Can We Identify the “Point of No Return”? Saeed, D.
2018
37 4S p. S46-S47
artikel
501 Identifying Potential Predictive Biomarkers of Successful Ex-vivo Lung Perfusion Morrison, M.I.
2018
37 4S p. S244
artikel
502 IL1RN Genotype and Infection Risk in Heart Recipients Ezzahouri, I.
2018
37 4S p. S218
artikel
503 Immunologic Characterization and Clinical Implication of CD4+CD57+T Cells in Patients with Acute Heart Failure Youn, J.
2018
37 4S p. S185-S186
artikel
504 Immunologic Impacts of Natural Killer Cell-Related Innate Immune Rejection Mediated by CD226 and NKG2D on the Engraftment of Syngeneic Cardiomyocyte Derived from Induced Pluripotent Stem Cell Nakamura, Y.
2018
37 4S p. S213
artikel
505 Immunosuppression Impact in Heart Transplant Recipients with Chagas' Disease in the Development of Cardiac Allograft Vasculopathy Data of an Argentine Center Peradejordi, M.A.
2018
37 4S p. S414-S415
artikel
506 Impact of Allograft Ischemic Time on Short- and Long-term Survival in Lung Transplantation Fakhro, M.
2018
37 4S p. S247-S248
artikel
507 Impact of a Mobile Health Intervention on Long-term Nonadherence in Lung Transplantation Rosenberger, E.M.
2018
37 4S p. S38
artikel
508 Impact of Anemia on Survival Among Patients with Durable Ventricular Assist Device: An Analysis of the Prevent Study Zalawadiya, S.
2018
37 4S p. S161
artikel
509 Impact of a Novel Shared Healthcare Delivery Model in Remotely Located Patients with Left Ventricular Assist Devices Yin, M.
2018
37 4S p. S277-S278
artikel
510 Impact of Candida Colonization on Lung Transplantation Green, J.S.
2018
37 4S p. S357
artikel
511 Impact of Carbon Dioxide Tension on Survival After Lung Transplantation for Pulmonary Fibrosis Villavicencio, M.A.
2018
37 4S p. S33
artikel
512 Impact of Concomitant Mitral Valve Surgery for Mitral Regurgitation During LVAD Implantation: Systematic Review and Meta-Analysis Choi, J.
2018
37 4S p. S75
artikel
513 Impact of Contemporary Ventricular Assist Device Therapy on Renal Outcomes in End Stage Heart Failure Xu, P.Z.
2018
37 4S p. S473-S474
artikel
514 Impact of Continuous Flow Left Ventricular Assist Device on Graft Rejection and Donor-specific Antibodies Development After Heart Transplant Carrozzini, M.
2018
37 4S p. S374-S375
artikel
515 Impact of Coronary Artery Calcification of the Donor Heart on Transmitted Coronary Artery Disease in Heart Transplant Recipients Kimura, Y.
2018
37 4S p. S414
artikel
516 Impact of Creatinine Excretion Rate, a Maker of Sarcopenia, on Prediction of Mortality and Neurological Events in Advanced Heart Failure Patients With Left Ventricular Assist Device Iwasaki, K.
2018
37 4S p. S279
artikel
517 Impact of Cytomegalovirus Transmission on Lung Allograft Survival in the United States Kurihara, C.
2018
37 4S p. S358-S359
artikel
518 Impact of Donor Lung Pathogenic Bacteria on Patient Outcomes in the Immediate Post-transplant Period Ahmad, O.
2018
37 4S p. S359
artikel
519 Impact of Donor Smoking History on Graft Survival Following Cardiac Transplantation Lamba, H.K.
2018
37 4S p. S173-S174
artikel
520 Impact of Genotype on Boys with Duchenne Muscular Dystrophy Gambetta, K.
2018
37 4S p. S122
artikel
521 Impact of Hepatic Fibrosis on Outcomes in Patients Undergoing Continuous-Flow LVAD Implantation Lamba, H.K.
2018
37 4S p. S386
artikel
522 Impact of Ischemic Time on Primary Graft Dysfunction: A National Analysis Anderson, K.
2018
37 4S p. S459
artikel
523 Impact of ISHLT Left Ventricular Primary Graft Dysfunction on Survival After Heart Transplant Martinez, J.J.
2018
37 4S p. S103-S104
artikel
524 Impact of Late Aortic Regurgitation in Patients with HeartMate II Matsumoto, Y.
2018
37 4S p. S369-S370
artikel
525 Impact of Late Onset CMV Replication After Heart Transplant Ponz de Antonio, I.
2018
37 4S p. S354
artikel
526 Impact of Lung Allograft Position on Lung Quality During Ex Vivo Lung Perfusion Ordies, S.
2018
37 4S p. S219
artikel
527 Impact of Massage Therapy in Lung Transplant Recipients Gauchez, H.
2018
37 4S p. S301
artikel
528 Impact of Neutropenia on Survival in Lung Transplant Recipients Receiving Mycophenolate for Immunosuppression Tague, L.K.
2018
37 4S p. S110-S111
artikel
529 Impact of Normothermic Ex-vivo-lung Perfusion on Early Post Transplantation Cytomegalovirus Infection Koch, A.
2018
37 4S p. S244-S245
artikel
530 Impact of Ongoing CPR on VA ECMO Outcomes Fujita, K.J.
2018
37 4S p. S47-S48
artikel
531 Impact of Pre-implant Illness Severity on Outcomes of Pediatric VAD Patients Butto, A.
2018
37 4S p. S158-S159
artikel
532 Impact of Pre-Procedural Planning with 3D Printed Models on Patient Outcomes for Ventricular Assist Device Placement in Adults with Congenital Heart Disease: Rationale and Design of a Multicenter Prospective Registry Farooqi, K.M.
2018
37 4S p. S194
artikel
533 Impact of Primary Graft Dysfunction on Allograft T Cell Chimerism Following Lung Transplantation Snyder, M.E.
2018
37 4S p. S82
artikel
534 Impact of Right Ventricular Function and Pulmonary Hypertension Therapy on Graft Dysfunction and Death in Lung Transplant Recipients Thornberg, M.
2018
37 4S p. S487
artikel
535 Impact of Severe Tricuspid Valve Insufficiency on the Performance of Left Ventricular Assist Device Sadat, N.
2018
37 4S p. S384-S385
artikel
536 Impact of Socioeconomic Factors on Patient Desire for LVAD Therapy Tchoukina, I.
2018
37 4S p. S189-S190
artikel
537 Impact of Tandem Heart Use for Heart Failure Patients as a Bridged to Long-term Continuous Flow Left Ventricular Assist Devices Kurihara, C.
2018
37 4S p. S321-S322
artikel
538 Impact of the Affordable Care Act on Patients Listed for Cardiac Transplant Ising, M.S.
2018
37 4S p. S237
artikel
539 Impact of the Thoracotomy Implant Approach on Average Length of Stay and Rehospitalizations in the HVAD LATERAL Trial Strueber, M.
2018
37 4S p. S83-S84
artikel
540 Impact of the Thoracotomy Implant Approach on Patient Self-Reported Quality of Life in the HVAD LATERAL Trial Cheung, A.
2018
37 4S p. S476
artikel
541 Impact on Outcomes with Extra-Corporeal Life Support (ECLS) After Complicated Pulmonary Thrombo-Endarterectomy Nair, H.
2018
37 4S p. S26
artikel
542 Impaired Baseline Renal Function May Not Influence Long Term Renal Function and Survival After LVAD Implantation Smail, H.
2018
37 4S p. S115-S116
artikel
543 Impaired Kidney Function and Impact on Survival After Left Ventricular Assist Device Implantation as a Bridge to Transplantation Vucicevic, D.
2018
37 4S p. S290-S291
artikel
544 Impaired Mitochondrial Quality Control in African Americans With Chronic Heart Failure Marek-Iannucci, S.
2018
37 4S p. S232-S233
artikel
545 Impella 5.0 as a Bridge-To Bridge Option after Extracorporeal Life Support. Lessons Learned from the First 15 Cases Zipfel, S.
2018
37 4S p. S376
artikel
546 Implantation Strategies and Outcomes of Patients Treated with Left Ventricular Assist Devices Awaiting for Heart Transplant in Europe and United States: Data from the TransAtlantic Registry on VAD and Transplant (TRAVIATA) Brambatti, M.
2018
37 4S p. S294
artikel
547 Implementation of a Multidisciplinary CODE SHOCK Strategy for Cardiogenic Shock Garuba, H.A.
2018
37 4S p. S293-S294
artikel
548 Implementing the Index for Mortality Prediction After Cardiac Transplantation Risk Scores to Optimize Resources Jeng, E.I.
2018
37 4S p. S429
artikel
549 Implication of Appropriate ICD Shock on Mortality After Continuous Flow LVAD Omery, B.
2018
37 4S p. S130
artikel
550 Implication of Pre-Operative Pulmonary Function Testing on Gastrointestinal Bleeding After Continuous Flow LVAD Askar, W.
2018
37 4S p. S368
artikel
551 Implications of the Refusal of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation Mulvihill, M.S.
2018
37 4S p. S138-S139
artikel
552 Implications of the Refusal of Increased Risk Donor Offers on Waitlist Survival in Lung Transplantation Cox, M.L.
2018
37 4S p. S200
artikel
553 Importance of Donor Hypoxemia in Lung Transplantation: A Comprehensive Analysis of Serial Blood Gases Daulton, R.
2018
37 4S p. S108
artikel
554 Important HLA and Non-HLA Pre-Transplant Determinantes Associated with the Development of De Novo Donor Specific Antibody After Lung Transplantation Zhang, A.
2018
37 4S p. S17
artikel
555 Improved Exercise Performance and Quality of Life with Right Ventricular Pacing Over Biventricular Pacing in LVAD Patients Chung, B.
2018
37 4S p. S131
artikel
556 Improved Long Term Outcomes after Heart Transplantation Utilizing Donors with Traumatic Mode of Brain Death Peled, Y.
2018
37 4S p. S324
artikel
557 Improved Lung Preservation in the Organ Care System in a Porcine Transplantation Setting Modelled After the INSPIRE Trial Triggers a Proregulatory T Cell Phenotype Salman, J.
2018
37 4S p. S88-S89
artikel
558 Improvement of Esophageal Dysmotility with Transelectrical Stimulation (TES) in Lung Transplant Patients Amaris, M.
2018
37 4S p. S242
artikel
559 Improvement of Quality of Life and Mental Recovery after Left Ventricular Assist Device Implantation compared to Heart Transplantation Barten, M.J.
2018
37 4S p. S478
artikel
560 Improving the Diagnosis of Rejection by Molecular Phenotype of Endomyocardial Biopsies: Single Center Insights from the Interheart Study Borgese, L.
2018
37 4S p. S304
artikel
561 Improving Utility of MELD-XI Prognostication in Heart Transplant Meguerdijian, R.
2018
37 4S p. S426
artikel
562 Incidence and Impact of Late Right Heart Failure After Continuous-flow Left Ventricular Assist Device Implantation Kurihara, C.
2018
37 4S p. S68-S69
artikel
563 Incidence and Impact of Severe LVAD-related Infections Requiring Surgical Treatment in Obesity Patients on Long-term HeartMate II and HeartWare Support Kurihara, C.
2018
37 4S p. S361-S362
artikel
564 Incidence and Management of Device-related Infections With the Jarvik 2000 Axial Flow Pump Gaillard, M.
2018
37 4S p. S363
artikel
565 Incidence and Outcomes of Cardiac Surgery After Orthotopic Heart Transplantation Simpson, M.T.
2018
37 4S p. S432-S433
artikel
566 Incidence and Outcomes of Post-lymphoproliferative Disorder in Lung Transplant Recipients. Analysis of the ISHLT Registry Zaffiri, L.
2018
37 4S p. S450
artikel
567 Incidence of Early and Late Pump Thrombosis on HeartMate II LVAD Support Ho, A.
2018
37 4S p. S369
artikel
568 Incidence of Heart Failure in Patients with Cardiac Tumor Surgical Resection: A Single Center Experience Ibarra-Cortez, S.H.
2018
37 4S p. S317-S318
artikel
569 Incidence of Treatable Ventricular Arrhythmias After VAD Placement in Children Wilkens, S.J.
2018
37 4S p. S122-S123
artikel
570 Incidence, Predictors and Outcomes of Severe Primary Graft Dysfunction in Pediatric Heart Transplant Recipients Profita, E.L.
2018
37 4S p. S96-S97
artikel
571 Increased Aortic Stiffness is Associated with Higher Rates of Stroke, GI-bleeding and Pump Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients Rosenblum, H.
2018
37 4S p. S32
artikel
572 Increased Bleeding Risk in LVAD Patients with Elevated Angiopoetin-2 and TNF-α: Analysis of the PREVENT Multicenter Study Kim, G.H.
2018
37 4S p. S71
artikel
573 Increased Phosphorylation of p70S6 Kinase is Associated With CMV Reactivation in Lung Transplant Patients Besa, V.
2018
37 4S p. S211-S212
artikel
574 Increased Plasma Levels of Donor-derived Cell-free DNA Correlate With Acute Rejection in the Recipients of Living Donor-lobar Lung Transplantation Tanaka, S.
2018
37 4S p. S230
artikel
575 Increased Pump Speed is Associated with Reduced Rates of Stroke on HeartMate II LVAD Support Schultz, J.N.
2018
37 4S p. S57-S58
artikel
576 Increased Risk of Rejection Following Itraconazole vs Nebulised Amphotericin For Fungal Prophylaxis After Heart Transplant Burrows, F.S.
2018
37 4S p. S418
artikel
577 Increased Use of Multi-organ Transplantation in Heart Transplantation‒Time Will Tell Lui, C.
2018
37 4S p. S340
artikel
578 Increase in DCD Donation in the United States May Adversely Impact DBD Heart Transplantation: Retrospective Analysis of a Limited UNOS Dataset Farr, M.
2018
37 4S p. S51
artikel
579 Increasing Frequency of CD127low Regulatory Cells Early After Lung Transplantation Improves Freedom From Chronic Lung Allograft Rejection and Graft Survival in 673 Patients Ius, F.
2018
37 4S p. S34
artikel
580 Increasing Use of Exceptions After Changes to Pediatric Heart Allocation Robinson, A.M.
2018
37 4S p. S61-S62
artikel
581 Induction Immunosuppressive Therapy in Cardiac Transplantation: A Systematic Review and Meta-analysis Briasoulis, A.
2018
37 4S p. S106-S107
artikel
582 Infection Predisposes to Thrombosis During Long Term VAD Support Castrodeza, J.
2018
37 4S p. S362-S363
artikel
583 Infections and Subsequent Events in the ENDURANCE and ENDURANCE Supplemental Trials Kormos, R.L.
2018
37 4S p. S177-S178
artikel
584 Inflammation and Innate Immune Activation During Ex Vivo Heart Perfusion Qi, X.
2018
37 4S p. S220
artikel
585 Inflammation and Lymphoid Neogenesis Induced by Deletion of Lymphatics in Healed Lung Isografts Show the Importance of Lymphatics in Lung Homeostasis and Function Wang, L.
2018
37 4S p. S174
artikel
586 Inflammatory Cytokine Profiles in 24-Hour Brain Stem Death Model Boon, A.C.
2018
37 4S p. S208
artikel
587 Inflow Cannula Position is Associated with Improvement in Mitral Regurgitation After Left Ventricular Assist Device Implantation Pasrija, C.
2018
37 4S p. S101-S102
artikel
588 Influence of Age on Pulmonary Vascular Function in Systemic Sclerosis: A Case Controlled Study Rimouche, A.
2018
37 4S p. S488
artikel
589 Influence of an IgM-enriched Intravenous Immunoglobulin-based Treatment on Regulatory T Cells in Patients with Donor Specific Antibodies After Lung Transplantation Ius, F.
2018
37 4S p. S89
artikel
590 Influence of Donor Sex and Mechanism of Death on Cardiac Transplant Recipient Early pAMR Incidence and Cardiovascular Death Hammond, M.B.
2018
37 4S p. S345
artikel
591 Inhaled Nitric Oxide Dependency at the End of Double-Lung Transplantation: A Boosted Propensity Score Cohort Analysis Godement, M.
2018
37 4S p. S460-S461
artikel
592 Inhibition of Neutrophil Serine Proteases by Alpha 1 Antitrypsin in Perfadex Preserves Primary Graft Functions of Transplanted Murine Donor Lungs Morrone, C.
2018
37 4S p. S123
artikel
593 Initial Combination Therapy With Riociguat and Ambrisentan in Pulmonary Arterial Hypertension: A Prospective Open-label Study Thakrar, M.V.
2018
37 4S p. S53-S54
artikel
594 Initial Experience with Bosentan for the Management of Pulmonary Hypertension after Heart Transplantation Santiago, E.
2018
37 4S p. S417
artikel
595 Initial Results of the DNA Based Transplant Rejection Test (DTRT): An NIH-NHLBI Funded Five Year Multicenter Prospective Study of Donor Specific Cell Free DNA in the Non-Invasive Detection of Rejection Following Heart Transplantation Zangwill, S.
2018
37 4S p. S150
artikel
596 Innate Immune Mediator BAL Concentrations and PGD After Lung Transplantation Diamond, J.M.
2018
37 4S p. S198-S199
artikel
597 INR Remote Monitoring is Associated with Improved Time in Therapeutic Range Following Left Ventricular Assist Device Implantation Nguyen, V.N.
2018
37 4S p. S309-S310
artikel
598 In Sensitized Pre-Transplant Patients, Does IVIG after Heart Transplant Have any Benefit? Patel, J.
2018
37 4S p. S440
artikel
599 Institution-based, Pharmacist-managed Anticoagulation in Patients with a Left Ventricular Assist Device Bibb, T.J.
2018
37 4S p. S310
artikel
600 Intellectual Disability and Pediatric Lung Transplantation Iyengar, A.
2018
37 4S p. S403-S404
artikel
601 Interaction Between Ischemic Interval and Donor Age on Adult Heart Transplant Outcomes in the Modern Era John, M.M.
2018
37 4S p. S137-S138
artikel
602 Inter-facility Collaboration to Decrease Acute Care Length of Stay Post LVAD Implantation Horstmanshof, D.
2018
37 4S p. S274
artikel
603 Interval Depression Screening and Quality of Life Relationships in Ventricular Assist Device Patients Schroeder, S.E.
2018
37 4S p. S478
artikel
604 Intracellular C3 Protects Human Airway Epithelial Cells from Oxidant-Stress Induced Apoptosis: Implications for Lung Allograft Injury Kulkarni, H.S.
2018
37 4S p. S215
artikel
605 Intracellular Remodeling in a Rodent Model of Cardiac Mechanical Unloading - Influence of Phospholamban on Expression of Cardiac Ion Currents Westhofen, S.
2018
37 4S p. S230
artikel
606 Intracoronary Implantation of Post-GCSF Stimulation Circulation-derived Autologous CD34+ Cells Reverses Cardiac Remodeling in Patients With End-stage Diffuse Coronary Artery Disease (CAD) - Phase I Early and Long-term Results Lee, F.
2018
37 4S p. S94
artikel
607 Intracoronary Intimal Thickness in Recipients of Hepatitis C-Positive Donor Hearts Zalawadiya, S.
2018
37 4S p. S105
artikel
608 Intra-corporeal Biventricular Assist Devices Using the HVAD in Children Schweiger, M.
2018
37 4S p. S410
artikel
609 Intraoperative Assessment of Right Ventricular Strain During Lung Transplant Using Tissue Tracking Technology Berardino, A.
2018
37 4S p. S255-S256
artikel
610 Intravascular Ultrasound in the Diagnosis of Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients: A 20 Year Single Center Review Kuhn, M.A.
2018
37 4S p. S191
artikel
611 Intravenous Inotropes, Beta Blockers and Survival in Ambulatory Heart Failure Patients - A Contemporary Analysis of 3,311 Patients Havakuk, O.
2018
37 4S p. S202
artikel
612 Intravenous Treprostinil Delivered by Implantable Pump for the Treatment of Pulmonary Arterial Hypertension - Report of First 11 Cases Rosengarten, D.
2018
37 4S p. S154
artikel
613 IPADS and LVADS: VAD Coordinator Telemonitoring Luke, A.
2018
37 4S p. S37
artikel
614 Iron Deficiency is Associated with Adverse Outcomes in Pediatric Heart Failure Puri, K.
2018
37 4S p. S405
artikel
615 Is Cerebral Near-infrared Spectroscopy Monitoring Predictive of Neurological Injury During ECMO? Liem, S.
2018
37 4S p. S30
artikel
616 Ischemia Reperfusion Injury Significantly Differs Between Lung vs. Heart Transplantation with Respect to Lead Cytokines and Correlation to Clinical Outcome Wiegmann, B.
2018
37 4S p. S219-S220
artikel
617 Ischemic but Not Dilative Cardiomyopathy Impairs the Thioredoxinsystem in the Myocardium Dieterlen, M.
2018
37 4S p. S322-S323
artikel
618 Ischemic HeartFailure Induces Simultaneous Downregulation of Myocardial E3 Ligases Dix, M.
2018
37 4S p. S186
artikel
619 Is Cold Storage Possible in DCD Heart Transplantation? A Pre-Clinical Study Ribeiro, R.
2018
37 4S p. S125-S126
artikel
620 Is Depression After Heart Transplantation (HTx) Associated With Impaired Survival During Long-term Follow-up? Bürker, B.S.
2018
37 4S p. S350
artikel
621 Is First-year DSA After Heart Transplantation Truly a Biomarker for the Development of Cardiac Allograft Vasculopathy? Patel, J.
2018
37 4S p. S438-S439
artikel
622 ISHLT 2018 Author Index 2018
37 4S p. S495-S524
artikel
623 ISHLT Consensus on Standardization of Bronchoalveolar Lavage in Lung Transplantation Martinu, T.
2018
37 4S p. S56-S57
artikel
624 Is Low-rpm a Risk Factor for Pump Thrombosis in Pediatric Patients with HeartWare HVAD? Kocabeyoglu, S.
2018
37 4S p. S408
artikel
625 Is Pre-Operative Colonoscopy Screening for LVAD Therapy Needed for Higher INTERMACS Profile Patients in the Current Era? Bansal, A.
2018
37 4S p. S468-S469
artikel
626 Is Pre-operative Dialysis a Contraindication to Continuous-flow Left Ventricular Assist Device (CF-LVAD) Implantation? Lamba, H.
2018
37 4S p. S291
artikel
627 Is the Current PGD Grading Still Valid in Modern Lung Transplantation? - A Retrospective Analysis of a High-Volume Center Schwarz, S.
2018
37 4S p. S199-S200
artikel
628 Is the Luminex 1:8 Dilution Truly the Poor Man’s C1q for Patients Awaiting Heart Transplantation? Kittleson, M.
2018
37 4S p. S438
artikel
629 Is the New ISHLT Criteria for Pulmonary Antibody-mediated Rejection Also a Severity Indicator? Agbor-Enoh, S.
2018
37 4S p. S15-S16
artikel
630 Is the VAS Quality of Life Assessment Tool Sensitive to Both Male and Female MCSD Patients? Coleman, B.
2018
37 4S p. S300-S301
artikel
631 It’s HLA-DR Not HLA-DQ Donor-specific Antibody That is Correlated to CAV After Heart Transplant Olymbios, M.
2018
37 4S p. S151-S152
artikel
632 IVC Assessment by Ultrasound in Acute and Ambulatory Heart Failure Patients Predictive of Mortality and Readmissions: A Systematic Review Rahman, T.
2018
37 4S p. S323
artikel
633 Jehovah Witness Patients: Should We Liberalize Criteria for Heart Transplantation? Sharoff, R.
2018
37 4S p. S434
artikel
634 Keeping Tacrolimus Levels Therapeutic: Step-Wise Protocol for Itraconazole Discontinuation Stephen, J.
2018
37 4S p. S307
artikel
635 Kidney Allografts Confer Tolerance Upon Co-Transplanted Heart Allografts by Promoting Tregs Yang, C.
2018
37 4S p. S175
artikel
636 Kinetics of Regulatory CD4 T Cells in Heart Recipients Under Induction Therapy With One-single Dose versus Two-dose Basiliximab Garcia, S.
2018
37 4S p. S345
artikel
637 Knockout of the M33 Receptor Gene in Murine Cytomegalovirus is Associated With Decreased Levels of Cardiac Allograft Vasculopathy in a Murine Aortic Transplant Model Heim, C.
2018
37 4S p. S23
artikel
638 Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients Undergoing Left Ventricular Assist Device Implantation Gregoric, I.D.
2018
37 4S p. S277
artikel
639 Laterality of Cerebral Artery Hemodynamics in Continuous-Flow LVAD Patients: A Pilot Study in Relation to Stroke Stöhr, E.J.
2018
37 4S p. S284
artikel
640 Left Ventricular Assist Device as Bridge-to-Transplant Therapy May Mitigate Elevated Pulmonary Vascular Resistance Han, J.J.
2018
37 4S p. S280
artikel
641 Left Ventricular Assist Devices in INTERMACS 1 Acute Cardiogenic Shock Patients Louis, C.
2018
37 4S p. S473
artikel
642 Left Ventricular Dysfunction in Potential Heart Donors and Its Impact on Recipient Outcomes Oras, J.
2018
37 4S p. S169
artikel
643 Length of Stay, Hospitalization Cost and Disposition in U.S. Adultinpatientsafter Left Ventricular Assist Device Implantation (2009-2014) Briasoulis, A.
2018
37 4S p. S485
artikel
644 Length of Time on Left Ventricular Assist Device Prior to Heart Transplant: Does it Affect Outcome? Nikolova, A.
2018
37 4S p. S368-S369
artikel
645 Leptin Modifies the Impact of BMI on Heart Failure Progression: The Obesity Paradox Unraveling Rame, J.E.
2018
37 4S p. S187
artikel
646 Less Invasive Left Ventricular Assist Device Implantation; Single Center Experience Saeed, D.
2018
37 4S p. S480
artikel
647 Less Invasive Left Ventricular Assist Device Implantation - 5-Year Survival and Post Transplant Outcomes Riebandt, J.
2018
37 4S p. S480
artikel
648 Leukocytes from Lung Transplant Recipients with Severe Primary Graft Dysfunction Adoptively Transfer Alloreactivity to Vessel Grafts Trans Vivo Knoefel, A.
2018
37 4S p. S83
artikel
649 Levosimendan Effects Benefit Weaning From Veno-Arterial Extracorporeal Life Support Zipfel, S.
2018
37 4S p. S383
artikel
650 Life During Long Term LVAD Support LaBuhn, C.J.
2018
37 4S p. S476
artikel
651 Linking Early Humoral Sensitization in Lung Transplant Recipients with Even Earlier Cellular Alloreactivity in Humanized Mice Siemeni, T.
2018
37 4S p. S82
artikel
652 Liver Fibrosis Predicts Survival After Heart Transplant Kransdorf, E.
2018
37 4S p. S420-S421
artikel
653 Living-donor Lobar Lung Transplantation Outcomes in Pediatric Patients Ueda, S.
2018
37 4S p. S404
artikel
654 Lobar Lung Transplantation from Brain-dead Donors in Pulmonary Hypertension Etienne, H.
2018
37 4S p. S256-S257
artikel
655 Long Distance Relationships - Does the Geographic Distance From the Transplant Centre Affect Lung Transplant Outcomes? Khoshbin, E.
2018
37 4S p. S440
artikel
656 Longer Donor Management Time by Organ Procurement Organizations Improves Survival in Heart Transplant Recipients Xia, Y.
2018
37 4S p. S181-S182
artikel
657 Longer Waitlist Time Places Blood Group O Patients at Greater Risk of Experiencing a Major CF LVAD Related Complication Saeed, O.
2018
37 4S p. S344
artikel
658 Longitudinal Development in Left Ventricular Volume, Mass and Function in Heart Transplant Recipients - Results From the NOCTET Trial Broch, K.
2018
37 4S p. S417
artikel
659 Longitudinal Mass Cytometric Profiling of BAL Cells in Lung Transplant Recipients Moshkelgosha, S.
2018
37 4S p. S216
artikel
660 Long-Term Changes in Pulmonary Haemodynamics after Continuous-Flow Left Ventricular Assist Device Implantation in Advanced Heart Failure Patients Giglio, A.F.
2018
37 4S p. S492
artikel
661 Long-Term Follow up and Predicting Factors of de Novo Aortic Regurgitation after LVAD Implantation Benedetti, G.
2018
37 4S p. S291
artikel
662 Long Term Graft Survival and Immediate Post-Operative Complications Between Patients with Ischemic and Idiopathic Dilated Cardiomyopathy Undergoing Cardiac Transplantation OKOH, A.K.
2018
37 4S p. S327
artikel
663 Long-Term Impact of Multiple Comorbid Risk Factors on Survival After LVAD Implantation Vidula, H.
2018
37 4S p. S379
artikel
664 Long-term Outcome of Patients Bridged to Recovery After Short-term Mechanical Circulatory Support for Cardiogenic Shock Cheng, Y.
2018
37 4S p. S28-S29
artikel
665 Long-term Outcomes of Adult Survivors of Pediatric Heart Transplantation Hong, B.
2018
37 4S p. S391
artikel
666 Long Term Outcomes of Ex Vivo Lung Perfusion: A Single Center 10 Year Experience Divithotawela, C.
2018
37 4S p. S148-S149
artikel
667 Long-term Results of an IgM-enriched Human Immunoglobulin-based Therapy for Early Donor Specific Antibodies After Lung Transplantation Ius, F.
2018
37 4S p. S109-S110
artikel
668 Long-term Results of Berlin Heart EXCOR Pediatric Implantation in Japan Ono, M.
2018
37 4S p. S409-S410
artikel
669 Long Term Results of Mechanical Circulatory Support as Bridge to Transplant in Severe Heart Failure Pediatric Patients Taira, M.
2018
37 4S p. S409
artikel
670 Long Term Survival Outcomes Following Heart Transplantation are Significantly Impacted by Recipient Smoking Status Yoeli, D.
2018
37 4S p. S428-S429
artikel
671 Low Allomap Ordinal and Variability Scores Are Associated with Increased Malignancy Post Heart Transplant cotarlan, v.
2018
37 4S p. S335-S336
artikel
672 Low AlloMap Variability Score Within the First 3 Years Post Heart Transplant is Associated with the Combined Endpoint of Death, Malignancy and Coronary Vasculopathy Post Heart Transplant Cotarlan, V.
2018
37 4S p. S336
artikel
673 Low Correlation Between PCWP and LVEDP in Patients With End-Stage Lung Disease Kafi, A.
2018
37 4S p. S450
artikel
674 Low-dose Prothrombin Complex Concentrates for Warfarin Reversal Prior to Heart Transplantation Wanek, M.R.
2018
37 4S p. S418
artikel
675 Lower Six Minute Walk distance or FEV1 Predict a Survival Benefit of Lung Transplantation compared to Medical Management for End Stage COPD Timofte, I.
2018
37 4S p. S165
artikel
676 Low Incidence of Right Heart Failure During Left Ventricular Assist Device Implantation Faerber, G.
2018
37 4S p. S381
artikel
677 Low Partial Pressures of Oxygen in Circulatory Death Donors is Associated with Decreased Survival in Lung Transplant Recipients Fiedler, A.G.
2018
37 4S p. S133
artikel
678 Low Serum TNF-α in a European Cohort Implanted with the HeartMate3 Left Ventricular Assist Device Netuka, I.
2018
37 4S p. S371-S372
artikel
679 Low Variability in Gene Expression Profile Scores Are Associated With Decreased Risk of Adverse Events Post Heart Transplantation: The Mid America Experience Beauchamp, S.R.
2018
37 4S p. S330-S331
artikel
680 Low Volume Centers have Inferior Post-Heart Transplant Survival Lamba, H.K.
2018
37 4S p. S435
artikel
681 Lung Microbiome and Metabolome Differentiates Allograft from Native Lung in Single Lung Transplant Recipients Sharma, N.S.
2018
37 4S p. S175
artikel
682 Lung Tissue Telomere Length in Chronic Lung Allograft Dysfunction Sacreas, A.
2018
37 4S p. S444
artikel
683 Lung Transplantation for Scleroderma Lung Disease: Indications, Survival and Prognosis Pradère, P.
2018
37 4S p. S164
artikel
684 Lung Transplantation in Children and Young Adults in Czech Republic: A Single Center Experience Dousova, T.
2018
37 4S p. S404
artikel
685 Lung Transplantation in Cystic Fibrosis Patients Infected With B.Cepacia Complex: A Single Center Experience Nechaev, N.
2018
37 4S p. S360
artikel
686 Lung Transplantation in Jehovah's Witness Patients- A Single Center Experience Scheinin, S.A.
2018
37 4S p. S239
artikel
687 Lung Transplantation in Turkey: One Year Balance Sheet Yeginsu, A.
2018
37 4S p. S255
artikel
688 Lung Transplant Wait list Outcomes After Implementation of the Revised Lung Allocation Score Pasupneti, S.
2018
37 4S p. S183
artikel
689 LVAD Does Not Improve Outcomes in Patients with Pulmonary Hypertension after Heart Transplantation Brown, C.R.
2018
37 4S p. S154
artikel
690 LVAD Patients with CKD: Are Two Organs Better than One? Kamath, M.Y.
2018
37 4S p. S116-S117
artikel
691 LVAD Pump Speed Increase is Associated with Improvement of Cardiac Output, O2 Kinetic and O2 Muscle Extraction Paolillo, S.
2018
37 4S p. S143
artikel
692 LVAD Pump Speed Increase is Associated With Increased Peak VO2 and Lower Cardiogenic Exercise Limitation Apostolo, A.
2018
37 4S p. S280
artikel
693 LVADs as Bridge to Candidacy in the UK Shaw, S.M.
2018
37 4S p. S266
artikel
694 LVAD versus BiVAD-mediated Allosensitization in Bridge-to-transplant Patients Chaidaroglou, A.
2018
37 4S p. S377
artikel
695 Lysophosphatidic Acid Drives Recruitment and Fibroblastic Differentiation of Mesenchymal Stromal Cells in Chronic Lung Allograft Dysfunction Sinclair, K.A.
2018
37 4S p. S40-S41
artikel
696 Macrophages Represent the Major Pool of Interleukin-7 Receptor-α Expressing Immune Cells in Patients with Myocarditis Kubin, N.
2018
37 4S p. S212
artikel
697 Management of Anticoagulation in Patients with LVAD Undergoing Elective Invasive Procedures or Surgeries Guglin, M.
2018
37 4S p. S372
artikel
698 Marijuana in Pediatric and Adult Congenital Heart Transplant Listing: A Survey of Provider Practices and Attitudes Phillips, K.A.
2018
37 4S p. S393
artikel
699 Matching Recipient and Donor Risks: Maximizing Benefits from Every Lung Transplant Zafar, F.
2018
37 4S p. S246-S247
artikel
700 MCS Shear-Medicated Platelet Activation Does not Cause Integrin GPIIbIIIa Activation, Rather Shedding and Microparticle Generation Roka-Moiia, Y.
2018
37 4S p. S162
artikel
701 Measuring EBV in Lung Transplant Patients - Lessons of 16 Years of Follow Up Gore, E.J.
2018
37 4S p. S356-S357
artikel
702 Mechanical Circulatory Support for Late Cardiac Allograft Failure Simpson, M.T.
2018
37 4S p. S433
artikel
703 Mechanical Support in Children with Restrictive Left Ventricle - Single Centre Experience Mahmood, A.
2018
37 4S p. S406
artikel
704 Mechanical Unloading Characteristics of the Impella 5.0 Axillary Pump Using a Hemodynamic-Echocardiographic Ramp Protocol Zern, E.K.
2018
37 4S p. S276-S277
artikel
705 Medication Adherence: Use of the Beliefs About Medication Questionnaire in Heart and Lung Transplant Patients Painter, L.
2018
37 4S p. S295-S296
artikel
706 Metabolomics Analysis in Chronic Thromboembolic Pulmonary Hypertension Heresi, G.A.
2018
37 4S p. S25
artikel
707 Microbial Biofilm Formation and Migration on Ventricular Assist Device Drivelines: Implications for Infection Qu, Y.
2018
37 4S p. S134
artikel
708 MicroRNAs Signature in Heart Transplant Enhances Diagnosis of Different Types of Acute Rejection Di Francesco, A.
2018
37 4S p. S39-S40
artikel
709 Midterm Followup of Heart Transplantation With Ex vivo Normothermic Preservation Using Extended Criteria Donor Hearts García Sáez, D.
2018
37 4S p. S14
artikel
710 Mid-term Survival after Ventricular Assist Device Implantation in Patients ≥70 Years Pizanis, N.
2018
37 4S p. S471
artikel
711 Minimal AnticoaGulation EvaluatioN To aUgment heMocompatibility - The MAGENTUM 1 Study Netuka, I.
2018
37 4S p. S72-S73
artikel
712 Minimally-invasive Implantation of a Centrifugal Continuous-flow Left Ventricular Assist Device is Associated With Decreased Early Right Ventricular Failure Psotka, M.
2018
37 4S p. S99
artikel
713 Minimally Invasive Left Ventricular Assist Device Implantation is Associated with Decreased Postoperative Right Ventricular Failure Pasrija, C.
2018
37 4S p. S87
artikel
714 miRNA Dysregulation in Chronic Lung Allograft Rejection. A Computational, Quantitative and In Situ Analysis Meloni, F.
2018
37 4S p. S305-S306
artikel
715 MiRNA's Profiling and Primary Graft Dysfunction: Novel Non-invasive Biomarkes Palleschi, A.
2018
37 4S p. S458-S459
artikel
716 Mitochondrial Integrity at Early Reperfusion Predicts Post-Ischemic Cardiac Graft Recovery Wyss, R.K.
2018
37 4S p. S222-S223
artikel
717 Mitochondrial Respiratory Function is Impaired in the Setting of Right Ventricular Remodeling Induced by Pressure Overload Noly, P.
2018
37 4S p. S53
artikel
718 Mitochondrial Transplantation Prolongs Cold Preservation Time in Murine Cardiac Transplantation Moskowitzova, K.
2018
37 4S p. S22-S23
artikel
719 Mitral Regurgitation Due to Ischemic Cardiomyopathy: Insights Using Computational, Robotics Mitral-Papillary-Ventricular Complex Park, J.
2018
37 4S p. S318-S319
artikel
720 Mitral Valve 3D Computational Modeling and Simulation Characterized by Left Ventricular Shape Dynamics in Dilated Cardiomyopathy Park, J.
2018
37 4S p. S230-S231
artikel
721 Mobile Integrated Healthcare - Community Paramedicine: An Integrated and Novel Approach to Caring for Heart Failure Patients Reynolds, G.
2018
37 4S p. S314
artikel
722 Mobilization of ECMO Patients with Various Cannulation Configurations Colclough, E.
2018
37 4S p. S59-S60
artikel
723 Model for End-Stage Liver Disease (MELD) Stratification Identifies Two Distinct Cohorts of Arrhythmogenic Right Ventricular Cardiomyopathy Patients Undergoing Transplantation Reza, N.
2018
37 4S p. S335
artikel
724 Model of Pediatric Pulmonary Hypertension and Right Heart Failure by Chronic Pulmonary Artery Ligation With Invasive Echocardiographic Evaluation Hala, P.
2018
37 4S p. S235-S236
artikel
725 Moderate to Severe Right Ventricular Failure in the Setting of Pulmonary Hypertension Resolves in Most Patients After Lung Transplantation El-Sayed Ahmed, M.M.
2018
37 4S p. S489
artikel
726 Modification of Complement Activity in Donor Lungs with Cigarette Smoke Exposure History Improves Post-Lung Transplantation Outcomes Patel, K.J.
2018
37 4S p. S127
artikel
727 Modification of Sleep Disordered Breathing after Increase in LVAD Pump Speed in HF Patients Bonini, N.
2018
37 4S p. S279-S280
artikel
728 Modified Surgical Technique of Normothermic Ex-Vivo Perfusion Reduces Cold Ischemic Time in Lung Transplantation During the EXPAND Trial Villavicencio, M.A.
2018
37 4S p. S55
artikel
729 Molecular Detection of Rejection-like Changes in Proximal Bronchial Mucosal Lung Transplant Biopsies: Initial Findings of the INTERLUNG Study Halloran, K.
2018
37 4S p. S80-S81
artikel
730 Molecular Diagnosis of Rejection Phenotypes in 889 Heart Transplant Biopsies: The INTERHEART Study Reeve, J.
2018
37 4S p. S27
artikel
731 Molecular Diagnosis of Rejection Phenotypes in Lung Transplant Biopsies: Initial Findings of the INTERLUNG Study Halloran, K.
2018
37 4S p. S80
artikel
732 Mortality From Neurological Complications While on Continuous-flow Left Ventricular Assist Device Support Kawabori, M.
2018
37 4S p. S482
artikel
733 Mortality Outcomes Related to Multi-drug Resistant Organisms in Cystic Fibrosis Lung Transplant Recipients: An International Society of Heart and Lung Transplantation (ISHLT) Registry Study Lay, C.
2018
37 4S p. S154-S155
artikel
734 Mucormycosis in Lung Transplant Recipients: A Systematic Review Wand, O.
2018
37 4S p. S359-S360
artikel
735 Multicenter Study to Determine Up to 5 Year Clinical Outcome of Heart Transplant Recipient Receiving Rituximab Versus Placebo Outcomes in Subjects Previously Randomized in the CTOT-11 Study Starling, R.C.
2018
37 4S p. S18
artikel
736 Multi-Drug Resistant Infection after Heart Transplantation: How Serious is This? Kittleson, M.
2018
37 4S p. S356
artikel
737 Multiple Listing Does Not Improve Outcomes in Lung Transplantation Joyce, D.
2018
37 4S p. S250-S251
artikel
738 “My Best Spirometry Numbers- What Do They Mean?” Mohanka, M.R.
2018
37 4S p. S448
artikel
739 Mycophenolic Acid Trough Levels Underestimate Drug Exposure in Pediatric Heart Transplant Patients Pak, J.
2018
37 4S p. S63
artikel
740 Myocardial Perfusion and the Relation to Central Hemodynamics in the Acute Phase After Heart Transplantation Clemmensen, T.S.
2018
37 4S p. S330
artikel
741 Narrative Review of Ethical Considerations in Pediatric Heart Transplantation Wilkens, S.J.
2018
37 4S p. S403
artikel
742 National Trends in Heart Donor Utilization Rates: What is in the Numbers? Jaeger, H.
2018
37 4S p. S172-S173
artikel
743 Natriuretic Doses of Mineralocorticoid Receptor Antagonists in Outpatients With Acute Decompensated Heart Failure Rosenblum, H.
2018
37 4S p. S41
artikel
744 Natural History of Mild Aortic Insufficiency at the Time of Left Ventricular Assist Device Implantation for Heartmate II and HVAD Kawabori, M.
2018
37 4S p. S75-S76
artikel
745 Natural Polyreactive Antibodies and Inflammatory Markers Following Left Ventricular Assist Device Implantation See, S.B.
2018
37 4S p. S213
artikel
746 Negative Impact of Ischemia on Short and Long Term Outcomes in Standard Criteria Double Lung Transplants Prospective Evidence from the OCS Lung INSPIRE International Trial Results Warnecke, G.
2018
37 4S p. S147
artikel
747 Negative Impact of Primary Graft Dysfunction Grade 3 within the Initial 72 Hours on Short and Long Term Clinical Outcomes in Standard Criteria Double Lung Transplants: Prospective Evidence from the OCS Lung INSPIRE International Trial Results Ardehali, A.
2018
37 4S p. S459-S460
artikel
748 Negative Pressure Wound Therapy Applied to Groin Cannulation Incisions Decrease the Incidence and Severity of Seroma Formation Bogar, L.J.
2018
37 4S p. S301
artikel
749 Neurocognitive Deficits are Prevalent in Ambulatory Patients Living with Left Ventricular Assist Devices Robinson, M.R.
2018
37 4S p. S11-S12
artikel
750 Neurohormonal Blockade Reduces Adverse Events During LVAD Support Mehta, P.
2018
37 4S p. S180-S181
artikel
751 Neurohormonal Blockade with Sacubitril/Valsartan in Left Ventricular Assist Device (LVAD) Patients Njue, F.
2018
37 4S p. S484
artikel
752 Neuron-Specific-Enolase as a Predictor of Overall and Neurological Outcome After Cardiopulmonary Resuscitation in Patients with VA-ECMO Schrage, B.
2018
37 4S p. S48
artikel
753 Neutrophil Extracellular Traps in Human Ex Vivo Lung Perfusion as a Biomarker of Lung Injury Caldarone, L.
2018
37 4S p. S33
artikel
754 Neutrophil to Lymphocyte Ratio at the Time of LVAD Implant Predicts 30-day Readmission Ahmed, N.
2018
37 4S p. S319
artikel
755 New Heart Allocation System to Rescue the Patients With Severe Biventricular Failure Saito, S.
2018
37 4S p. S342-S343
artikel
756 New-Onset Cognitive Impairment after Cardiac Transplantation in Children Rizwan, R.
2018
37 4S p. S192
artikel
757 Nitrite Attenuates Ischemia/Reperfusion (I/R) Injury of Lung by Regulating Endothelial Barrier Function Kumar, A.
2018
37 4S p. S224
artikel
758 NK Cells in Endomyocardial Biopsies From Cardiac Allografts: Detection, Quantification, and Precise Localization Using Multiplex Immunofluorescence Terada, M.
2018
37 4S p. S304
artikel
759 Non Invasive Monitoring of Acute Allograft Rejection in Heart Transplantation: Long-term Outcomes of the “No Biopsy Approach” Vallee, A.
2018
37 4S p. S326
artikel
760 Non-invasive Right Ventricle-pulmonary Artery Coupling Predicts Events in Pulmonary Arterial Hypertension and in Left Heart Disease Vicenzi, M.
2018
37 4S p. S205-S206
artikel
761 Non Ischemic Heart Preservation Nilsson, J.
2018
37 4S p. S13
artikel
762 Non-standard Donor Organs in Pediatric Lung Transplantation Have No Negative Impact on Recipients Outcome Sommer, W.
2018
37 4S p. S98
artikel
763 Normal Serum Lactic Acid is Discordant with Shock in Advanced Heart Failure Patients Narang, N.
2018
37 4S p. S67-S68
artikel
764 Novel Methods for Assessing Response to Desensitization Kransdorf, E.
2018
37 4S p. S439
artikel
765 Novel Minimally Invasive Surgical Approach for Refractory Cardiogenic Shock: A Hemodynamic Comparison With Current Percutaneous Strategies Akanni, O.
2018
37 4S p. S44-S45
artikel
766 Novel Rat Lung Transplant Model of Primary Graft Dysfunction by Histone Administration Nakao, K.
2018
37 4S p. S227
artikel
767 Novel Technique to Reduce Warm Ischemic Time During Cardiac Implantation Morcos, K.
2018
37 4S p. S425
artikel
768 Novel Virtual Reality Techniques Improve Virtual Implantation of Total Artificial Heart in the Pediatric Population Moore, R.A.
2018
37 4S p. S66
artikel
769 NT-proBNP Levels Are Reduced Following Treatment With Growth Hormone in Chronic Heart Failure Due to Ischemic Heart Disease. A Randomized Double Blind Placebo Controlled Trial Bobbio, E.
2018
37 4S p. S187-S188
artikel
770 Number of Refusals Due to Donor Quality Does Not Impact Lung Transplantation Outcomes Singh, E.
2018
37 4S p. S97
artikel
771 Nutritional Rehabilitation of Pediatric Patients on Ventricular Assist Device Support Hollander, S.A.
2018
37 4S p. S65
artikel
772 Observations on the Early Natural History of Auto- and Allospecific Antibodies After Lung Transplantation Abelson, D.
2018
37 4S p. S109
artikel
773 Older Donors Into Older Recipients: Still Contentious But Reasonable Rafiei, M.
2018
37 4S p. S50-S51
artikel
774 Older Kidney Donors in Dual Heart-kidney Transplantation: How Do They Stack Up? Dimbil, S.
2018
37 4S p. S352-S353
artikel
775 Omega-3 Reduces Gastrointestinal Bleeding in Patients With Continuous-flow Left Ventricular Assist Device Imamura, T.
2018
37 4S p. S163-S164
artikel
776 One Tac Trial: Renal Function After Conversion from Twice Daily to Extended Release Tacrolimus Baran, D.A.
2018
37 4S p. S420
artikel
777 One Year- Outcomes Following Heart Transplantation from Donation After Circulatory Determined Death (DCD) Donors Hudson, V.
2018
37 4S p. S197-S198
artikel
778 Optimal Characteristics of Donor Hearts With Diminished Left Ventricular Function Davila, A.B.
2018
37 4S p. S170-S171
artikel
779 Optimal Hemodynamics During LVAD Support Are Associated with Reduced Hemocompatibility-related Adverse Events Imamura, T.
2018
37 4S p. S44
artikel
780 Optimal Hemodynamics During LVAD Support Are Associated With Reduced Readmission Rate Imamura, T.
2018
37 4S p. S486-S487
artikel
781 Optimizing Hemodynamics Does Not Improve the Pulmonary Artery Pulsatility Index’s Post-LVAD Right Ventricular Failure Predictive Value Kumar, S.
2018
37 4S p. S373
artikel
782 Optimizing Immunosuppression: Steroid Weaning Strategies in Heart Transplant (HT) Khuu, T.
2018
37 4S p. S91
artikel
783 Optimizing Outcomes after Heart Transplantation in Patients with Cardiac Amyloidosis - A Single Center Analysis of 48 Patients in 2 Eras Kreusser, M.M.
2018
37 4S p. S92
artikel
784 Optimizing Perfusion of Human DCD Hearts in an Ex-Vivo System, and Histologic Assessment Roy, N.
2018
37 4S p. S228
artikel
785 Optimizing Weight-based Enoxaparin Dosing for Lung Transplant Recipients Veasey, T.M.
2018
37 4S p. S307-S308
artikel
786 OPUS Registry: Switching to Macitentan From Other Endothelin Receptor Antagonists (ERAs) Ravichandran, A.
2018
37 4S p. S153
artikel
787 Organ Sequence Number (SN) is Not a Proxy for Organ Quality Harhay, M.
2018
37 4S p. S245
artikel
788 Organ-specific Differences in a Thymoglobulin and Belatacept-based Protocol for Tolerance Induction in Non-human Primates Sommer, W.
2018
37 4S p. S216-S217
artikel
789 Outcome and Primary Endpoint Results From a Prospective Multi-center Study of Myocardial Recovery Using LVADs: Remission from Stage D Heart Failure (RESTAGE-HF) Birks, E.J.
2018
37 4S p. S142
artikel
790 Outcome of Cardiac Retransplantation for Late Allograft Failure: A Fifteen-Year Single Center Experience Simpson, M.T.
2018
37 4S p. S433
artikel
791 Outcome of CentriMag BiVAD Support for Cariogenic Shock Schibilsky, D.
2018
37 4S p. S290
artikel
792 Outcome of Centrimag Extracorporeal Mechanical Circulatory Support Use in Critical Cardiogenic Shock (INTERMACS 1) Patients Mehta, V.
2018
37 4S p. S285
artikel
793 Outcome of Heart-Lung or Double-Lung Transplantation in Pulmonary Hypertension Secondary to Congenital Heart Diseases Hascoet, S.
2018
37 4S p. S241
artikel
794 Outcomes After Isolated Durable Right Ventricular Assist Device Birati, E.Y.
2018
37 4S p. S85-S86
artikel
795 Outcomes After Left Ventricular Assist Device Implant in Patients Requiring Peri-operative Dialysis Hernandez, G.A.
2018
37 4S p. S470
artikel
796 Outcomes After Lung Transplantation for Patients with Occupational Lung Diseases Joubert, K.D.
2018
37 4S p. S254
artikel
797 Outcomes After Lung Transplantation in the Elderly Furuya, Y.
2018
37 4S p. S240
artikel
798 Outcomes Among Lung Transplant Recipients with Elevated Left Heart Filling Pressures and Primary Graft Dysfunction Elnahas, S.
2018
37 4S p. S258-S259
artikel
799 Outcomes and Risk Factor of Mechanical Circulatory Support by Periferal Veno-arterial Extrocorporal Membrane Oxygenation at Heart Transplant Candidates Needing Urgent Heart Transplantation Poptsov, V.N.
2018
37 4S p. S285-S286
artikel
800 Outcomes Associated With Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-analysis Lange, N.
2018
37 4S p. S90-S91
artikel
801 Outcomes Following Mitraclip in Advanced Heart Failure Patients: A Meta-Analysis Belkin, M.N.
2018
37 4S p. S201
artikel
802 Outcomes Following Use of a Novel Treatment Protocol for Antibody Mediated Rejection After Lung Transplantation Rusanov, V.
2018
37 4S p. S457
artikel
803 Outcomes in Heart Transplantation for Adults with Congenital Heart Disease- Contemporary Analysis and Development of a Risk Model - ReDoT Score Robinson, M.R.
2018
37 4S p. S93
artikel
804 Outcomes in Late Right Heart Failure after LVAD:A Contemporary Analysis of the New Intermacs 4.0 Definition Rame, J.E.
2018
37 4S p. S86
artikel
805 Outcomes in Patients Bridged to Long-term Continuous Flow Left Ventricular Assist Devices Using Short-term Impella Device Kurihara, C.
2018
37 4S p. S69
artikel
806 Outcomes of Children With Congenital Heart Disease Implanted With Ventricular Assist Devices: Analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Peng, D.M.
2018
37 4S p. S159
artikel
807 Outcomes of Combined Patent Foramen Ovale Repair and Lung Transplantation El-Sayed Ahmed, M.M.
2018
37 4S p. S256
artikel
808 Outcomes of Continuous Flow Left Ventricular Assist Devices: A Single Institutional 18-Year Experience with Over 850 Devices Lamba, H.K.
2018
37 4S p. S386-S387
artikel
809 Outcomes of Durable Mechanical Circulatory Support in Myocarditis: Analysis of the IMACS Registry Al-Kindi, S.G.
2018
37 4S p. S194-S195
artikel
810 Outcomes of ECMO Bridge to Lung Transplantation are Dependent on Age Caceres Polo, M.
2018
37 4S p. S168
artikel
811 Outcomes of Extended Criteria Cardiac Transplantation versus Destination Left Ventricular Assist Device Therapy Loforte, A.
2018
37 4S p. S268
artikel
812 Outcomes of Heart Transplant Recipients with LVAD Implantation as Destination Therapy versus Bridge to Transplantation Ahmad, K.
2018
37 4S p. S351
artikel
813 Outcomes of Long-term Inotrope Therapy as a Bridge to Heart Transplant Lee, E.C.
2018
37 4S p. S312
artikel
814 Outcomes of Lung Transplantation Following Hematopoietic Stem Cell Transplantation Shitenberg, D.
2018
37 4S p. S257-S258
artikel
815 Outcomes of Lung Transplantation for Patients Undergoing Previous or Simultaneous Cardiac Surgery Niikawa, H.
2018
37 4S p. S164-S165
artikel
816 Outcomes of Lung Transplantation in Septuagenarian Recipients Aguilar, P.R.
2018
37 4S p. S239
artikel
817 Outcomes of Myocarditis in Patients with Normal Left Ventricular Systolic Function on Admission Barfuss, S.B.
2018
37 4S p. S393-S394
artikel
818 Outcomes of Patients Bridged with LVAD to a Repeat Heart Transplant as Compared to Medical Management: Analysis of the UNOS Database Fugar, S.
2018
37 4S p. S266-S267
artikel
819 Outcomes of Telehealth Assessment of Lung Transplant Candidates Sidhu, A.
2018
37 4S p. S38
artikel
820 Outcomes of the Cardiac Transplantation with Opioid Overdose Donors Oh, K.
2018
37 4S p. S338-S339
artikel
821 Outcomes Using HVAD for Long-term Biventricular Support Kawabori, M.
2018
37 4S p. S481-S482
artikel
822 Overall Satisfaction and Adjustment After LVAD Using the QOLVAD Soni, M.
2018
37 4S p. S475
artikel
823 Overexpression of SOCS3 Attenuates Tracheal Allograft Rejection in the Early Phase After Murine Heterotopic Tracheal Transplantation by the Inhibition of Th1 Response Mesaki, K.
2018
37 4S p. S209
artikel
824 Palliative Care Consultation in Cardiogenic Shock Requiring Short-term Mechanical Circulatory Support- A Retrospective, Description of Timing and Utilization From a Single Institution Nakagawa, S.
2018
37 4S p. S478-S479
artikel
825 Panel Reactive Antibodies and Outcomes Following Heart Transplantation in Adults with Congenital Heart Disease Alshawabkeh, L.
2018
37 4S p. S107-S108
artikel
826 PAPi Shows a Stronger Correlation With RAP versus RVSWI in Both HFrEF and HFpEF Nair, N.
2018
37 4S p. S321
artikel
827 Parallel Improvements in Physical Symptoms and Depression in Response to Left Ventricular Assist Device Implantation Lee, C.S.
2018
37 4S p. S298-S299
artikel
828 Pathological Correlation Between Apical Core Biopsies at the Time of Left Ventricular Assist Device Implantation and Excised Heart at Time of Transplant or Autopsy Alhussein, M.
2018
37 4S p. S304-S305
artikel
829 Pathology Antibody-Mediated Rejection Plus Circulating Donor-Specific Antibodies Increase Development of Cardiac Allograft Vasculopathy After Heart Transplantation Kittleson, M.
2018
37 4S p. S437-S438
artikel
830 Patients Bridged to Transplant with Durable LVAD Support Have a Higher Risk of Post-Transplant De Novo Donor Specific Antibodies Cole, R.T.
2018
37 4S p. S150-S151
artikel
831 Patient Survival and Therapeutic Outcomes in the UK Bridge to Heart Transplant Ventricular Assist Device Population Rushton, S.
2018
37 4S p. S267-S268
artikel
832 Pattern Discovery of Most Common Sequential Adverse Events after Left Ventricular Assist Device (LVAD) Implant Movahedi, F.
2018
37 4S p. S382-S383
artikel
833 Patterns of ED Utilization for LVAD Patients Compared to non-LVAD Patients Al-Ani, M.
2018
37 4S p. S268
artikel
834 Patterns of Gene Expression in High GEP Score Samples Correlated with Clinical Factors in the Outcomes AlloMap Registry Pinney, S.P.
2018
37 4S p. S49
artikel
835 PDGF Receptor Blockade is Associated With Decreased Development of Cardiac Allograft Vasculopathy in a Murine Aortic Transplant Model Heim, C.
2018
37 4S p. S126
artikel
836 Pediatric Donor-Recipient Size Matching - Seeing is Believing, Or is it? Plasencia, J.
2018
37 4S p. S402-S403
artikel
837 Pediatric Heart Transplantation: Transitioning to Adult Care TRANSIT Pahl, E.
2018
37 4S p. S392-S393
artikel
838 Pediatric Heart Trasplantation in Spain. Data From the National Registry Guereta, L.G.
2018
37 4S p. S396-S397
artikel
839 Percutaneous Unloading of the Left Ventricle During Extracorporeal Membrane Oxygenation in Cardiogenic Shock - Ongoing Experience from a High-Volume Centre Schrage, B.
2018
37 4S p. S28
artikel
840 Perioperative Ischemic Reperfusion Injury, Aggravated by Prolonged Cardiac Ischemic Time, May Cause Temporary Deterioration of Allograft Function Nakamura, Y.
2018
37 4S p. S431
artikel
841 Phosphodiesterase-type 5 Inhibition for Refractory Pre-capillary PH in Advanced Heart Failure is Associated with Increased Early Mortality Post Heart Transplant Ayers, M.
2018
37 4S p. S418-S419
artikel
842 Phosphorylated P70 S6 Kinase and S6 Ribosomal Protein Value as Diagnostic Marker of Antibody-mediated Rejection in Lung Allografts: A Multicenter Study Calabrese, F.
2018
37 4S p. S80
artikel
843 Pilot Experience with a Novel Bluetooth Tablet-Based Technology for Home Monitoring and Education After Lung Transplantation Schenkel, F.A.
2018
37 4S p. S38
artikel
844 Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education Breathett, K.
2018
37 4S p. S316
artikel
845 Pitfalls in the Real-World Diagnosis and Management of Clinical Antibody Mediated Rejection of the Lung Abelson, D.
2018
37 4S p. S108-S109
artikel
846 Platelet Function, von Willebrand Factor and Hemocompatibility-related Adverse Events in Heartmate 3 and Heartmate II Patients: A Propensity Score Matched Study Zayat, R.
2018
37 4S p. S366
artikel
847 Polymorphisms in the KCNJ11 Gene are Associated with New Onset Diabetes After Lung Transplantation Henricksen, E.
2018
37 4S p. S90
artikel
848 Poor Outcomes on the Waiting List for Pediatric Lung Retransplant Patients Listed in Low Volume Centers Scully, B.B.
2018
37 4S p. S62
artikel
849 Poor Out-patient Clinic Appointment Compliance is a Predictor of Post-Heart Transplant Mortality in Children Dentel, J.
2018
37 4S p. S63-S64
artikel
850 Porcine Model of Sepsis-Induced Systemic Inflammation and Acute Lung Injury: Can Injured Lungs be Recovered with EVLP alone? Menaouar, A.
2018
37 4S p. S228-S229
artikel
851 Portable Normothermic Perfusion for Critical Marginal Graft Use: A Clinical-Pathological Comparison with Standard Marginal Donors Stored with Cold Preservation Schiavon, M.
2018
37 4S p. S54-S55
artikel
852 Poscadiotomy Cardiogenic Shock: Characteristics, Management and Prognostic in a Contemporary Cohort Vázquez López-Ibor, J.
2018
37 4S p. S319-S320
artikel
853 Post-cardiotomy as indication comes with its own predictors of mortality in Veno Arterial Extra Corporal Life Support Proudfoot, A.G.
2018
37 4S p. S378-S379
artikel
854 Posterior Reversible Encephalopathy Syndrome After Lung Transplant: Clinical Characteristics and Outcomes Bottiger, B.
2018
37 4S p. S252-S253
artikel
855 Post-Heart-Transplant Outcome Following Successful Bridge to Heart Transplantation With CentriMag BiVAD Support Schibilsky, D.
2018
37 4S p. S101
artikel
856 Post-Transplant Assessment of Donation after Circulatory Death (DCD) Cardic Allografts with MRI - An Update Pavlushkov, E.
2018
37 4S p. S15
artikel
857 Post Transplant Lymphoproliferative Disease in Two Recipients From a Single Donor, Donor Derived Disease? Shtraichman, O.
2018
37 4S p. S139-S140
artikel
858 Post-transplant Mortality and the Components of Donor Organ Ischemic Time in Pediatric Heart Transplantation Davies, R.R.
2018
37 4S p. S397-S398
artikel
859 Post-Transplant Outcomes of Patients Initially Receiving Left Ventricular Assist Device as Either Bridge to Candidacy or Destination Therapy Han, J.
2018
37 4S p. S328-S329
artikel
860 Potential Transplant Recipient Sequence Numbers Do Not Correlate with Worse Patient Outcomes Chen, C.W.
2018
37 4S p. S341-S342
artikel
861 Practice Variation in Detection of Coronary Allograft Vasculopathy (CAV) in Children: A Pediatric Heart Transplant Study Pahl, E.
2018
37 4S p. S393
artikel
862 Practice Variation in the Diagnosis of Acute Rejection Among Pediatric Heart Transplant Centers: An Analysis of the Pediatric Heart Transplant Study (PHTS) Database Godown, J.
2018
37 4S p. S191
artikel
863 Pre-Cannulation IL-10 Levels Predict Who Will Develop Acute Kidney Injury on VA-ECMO Leacche, M.
2018
37 4S p. S116
artikel
864 Pre-Cannulation SOFA Score is a Strong Predictor of Vasoplegia in Veno-Arterial Extra-Corporal Life Support Patients Leacche, M.
2018
37 4S p. S482-S483
artikel
865 Precision Medicine for Tacrolimus Dosing in Heart Transplant Recipients Yang, Y.
2018
37 4S p. S416
artikel
866 Predicting Acute and Chronic Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Device Implant: The Importance of Right Atrial Strain and Regional Deformation of the Right Ventricular Free Wall Iacovoni, A.
2018
37 4S p. S381-S382
artikel
867 Predicting Post-LVAD Mortality Across a Diverse HF Population Using Bayesian Analysis Kanwar, M.
2018
37 4S p. S463
artikel
868 Predicting Risk of Early Readmission in Lung Transplant Recipients Using dd-cfDNA Ahmad, K.
2018
37 4S p. S449
artikel
869 Prediction of Mortality in Decompensated Heart Failure by Invasive Hemodynamics Compared to Clinical Assessment Narang, N.
2018
37 4S p. S317
artikel
870 Predictive Cytokine Profile for Invasive Aspergillosis in Lung Transplant Recipients in the Setting of Pre-emptive Prophylaxis Herrera, S.
2018
37 4S p. S216
artikel
871 Predictive Value of I-CARS for LV Recovery in an Unselected cf-LVAD Cohort Jain, P.
2018
37 4S p. S274-S275
artikel
872 Predictive Value of Mean Arterial Pressure Versus Systolic Blood Pressure and Visit-To-Visit Blood Pressure Variability for Stroke and Pump Thrombosis in HeartMate II Patients Pinsino, A.
2018
37 4S p. S32
artikel
873 Predictors and Outcomes of Readmission After Heart Transplantation: An Analysis of UNOS/OPTN Data From 2000 to 2015 Givens, R.C.
2018
37 4S p. S353
artikel
874 Predictors for Early and Late Right Heart Failure After Left Ventricular Assist Device Implantation Stendardi, W.F.
2018
37 4S p. S374
artikel
875 Predictors for Health Related Quality of Life in De Novo Heart Transplant Recipients Rolid, K.
2018
37 4S p. S296
artikel
876 Predictors for Left Ventricular Assist Device Thrombosis Shore, S.
2018
37 4S p. S366
artikel
877 Predictors for Right Ventricular Failure After Bridge to Left Ventricular Assist Device by Extracorporeal Life Support Tsyganenko, D.
2018
37 4S p. S86-S87
artikel
878 Predictors of Airway Dehiscence Following Lung Transplantation Zhou, X.
2018
37 4S p. S449
artikel
879 Predictors of Dialysis Dependent Renal Failure in Patients Requiring Total Artificial Heart Support Desai, K.
2018
37 4S p. S117
artikel
880 Predictors of Donor Utilization in Lung Transplantation Singh, E.
2018
37 4S p. S56
artikel
881 Predictors of Early and Late Mortality after Heart Transplantation in Patients Bridged with the Total Artificial Heart Sawey, E.J.
2018
37 4S p. S345-S346
artikel
882 Predictors of Hemodynamic Success in Advanced CHF Patients Supported by Ambulatory Counterpulsation Jeevanandam, V.
2018
37 4S p. S179-S180
artikel
883 Predictors of Long Term Survival in Patients With Cystic Fibrosis Following Lung Transplantation Robinson, C.A.
2018
37 4S p. S446
artikel
884 Predictors of Mortality in Acute Right Ventricular Failure in Severe Pre-capillary Pulmonary Hypertension Treated by Dobutamine Rietz, M.
2018
37 4S p. S489-S490
artikel
885 Predictors of Neurologic Outcomes After Extracorporeal Cardiopulmonary Resuscitation Han, J.
2018
37 4S p. S469
artikel
886 Predictors of Postoperative Vasoplegia in Patients Receiving Left Ventricular Assist Devices Han, J.
2018
37 4S p. S127-S128
artikel
887 Predictors of Posttraumatic Growth Post Lung Transplant Airdrie, S.
2018
37 4S p. S21-S22
artikel
888 Predictors of Respiratory Failure in Patients Supported with Continuous Flow Ventricular Assist Devices and the Effect on Survival Sagebin, F.
2018
37 4S p. S375
artikel
889 Predictors of Survival to Discharge After VA-ECMO Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock Fried, J.A.
2018
37 4S p. S466-S467
artikel
890 Predictors of Systolic Heart Failure and Mortality Following Orthotopic Liver Transplantation: A Single-center Cohort Doctorian, T.
2018
37 4S p. S41-S42
artikel
891 Preemptive Tuberculosis Prophylaxis vs. Watchful Waiting After Heart Transplantation Poglajen, G.
2018
37 4S p. S178
artikel
892 Preemptive vs. Upfront CMV Prophylaxis Strategies and Risk of Non-CMV Herpesvirus Infections in Intermediate Risk Heart Transplant Recipients Eng, N.
2018
37 4S p. S178
artikel
893 Preemptive vs. Upfront CMV Prophylaxis Strategies and the Risk of Treated CMV in Intermediate Risk Heart Transplant Recipients Chen, C.
2018
37 4S p. S355-S356
artikel
894 Pregnancy Outcomes in 91 Female Heart Transplant Recipients Punnoose, L.R.
2018
37 4S p. S93-S94
artikel
895 Pre-implantation Hepatic Imaging as a Predictor of LVAD Morbidity van Niekerk, C.J.
2018
37 4S p. S470-S471
artikel
896 Pre-implant Phosphodiesterase-5 Inhibitor Use is Associated With Higher Rates of Severe Early Right Heart Failure After LVAD Implantation: An INTERMACS Analysis Gulati, G.
2018
37 4S p. S195
artikel
897 Preoperative Epidural Placement Provides Effective Analgesia Without Added Morbidity in Lung Transplantation Heng, E.E.
2018
37 4S p. S258
artikel
898 Preoperative Epidural Use in Lung Transplantation: A New Frontier in Pain Management? Krishnan, A.
2018
37 4S p. S461
artikel
899 Preoperative Patient Optimization Using Low Dose Levosimendan Improves Outcomes of Patients After Left Ventricular Assist Device Implantation Kocabeyoglu, S.
2018
37 4S p. S484-S485
artikel
900 Pre-Operative Pectoralis Muscle Measures by Computed Tomography Predict Early Right Heart Failure Deaths After Left Ventricular Assist Device Cogswell, R.
2018
37 4S p. S468
artikel
901 Pre-Operative Pectoralis Muscle Quantity and Attenuation by Computed Tomography are Predictive of Recurrent Gastrointestinal Bleeding on Left Ventricular Assist Device Support Cogswell, R.
2018
37 4S p. S73
artikel
902 Preoperative Predictors of Early Right Ventricular Failure After Left Ventricular Assist Device Implantation for Stable Patients in Intermacs 3-5 Status Ruiz-Cano, M.J.
2018
37 4S p. S464-S465
artikel
903 Pre-Operative Tricuspid Regurgitation and Right Ventricular Enlargement are Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices Liebo, M.
2018
37 4S p. S73-S74
artikel
904 Preoperative Use of Amiodarone is Associated With Perioperative Morbidity, But Not Mortality in Pediatric Heart Transplant Recipients Amdani, S.M.
2018
37 4S p. S401
artikel
905 Pre-PTE Pulmonary Artery Elastance, Right Ventricular Elastance, and RV-PA Coupling Predict Post-Operative Length of Stay and Hemodynamics Contijoch, F.
2018
37 4S p. S24-S25
artikel
906 Presence of de Novo Donor-Specific Antibodies to HLA-DQ in Lung Transplant Recipients Predicts Poor Survival Belloli, E.A.
2018
37 4S p. S442-S443
artikel
907 Pre-transplant Amiodarone Reduces Weight-based Tacrolimus Dosing Requirements in Heart Transplant Recipients Breslin, N.T.
2018
37 4S p. S306
artikel
908 Pretransplant Amiodarone Use and Post-transplant Outcomes in Pediatric Heart Transplant: A Propensity Score Analysis of the ISHLT Transplant Registry Butts, R.
2018
37 4S p. S400
artikel
909 Pre-transplant Anti-nuclear Antibodies Correlate With Post-transplant Donor-specific Antibodies: A Link between Autoimmunity and Graft Failure? McMullen, P.
2018
37 4S p. S302-S303
artikel
910 Pre-transplant Distress and Risk of Early Death in UK Cardiothoracic Transplant Recipients Malpus, Z.G.
2018
37 4S p. S20-S21
artikel
911 Pre-Transplant Estimated Glomerular Filtration Rate Less Than 40 Provides Similar Risks of Post-transplant Mortality Both in LVAD and Non-LVAD Heart Transplant Recipients Ando, M.
2018
37 4S p. S94
artikel
912 Pre-Transplant Evaluation of Patients with History of Skin Cancer: Survey Among Lung Transplant Centers, and The Outcome from a Single Center Intervention Emtiazjoo, A.M.
2018
37 4S p. S164
artikel
913 Pre-transplant Ex Vivo Recipient-derived Regulatory T Cell Therapy of the Lung Allograft Miyamoto, E.
2018
37 4S p. S95-S96
artikel
914 Pre-Transplant Hemoglobin A1c Predicts Long Term Outcomes Following Heart Transplantation Truby, L.K.
2018
37 4S p. S328
artikel
915 Pre-transplant Macrophage Cholesterol Efflux Capacity is Associated With Angiographic Cardiac Allograft Vasculopathy in a Multi-center Observational Study Javaheri, A.
2018
37 4S p. S35-S36
artikel
916 Pre-Transplant Memory/Antibody Status Predicts Rejection Risk in the First-Year After Heart Transplantation Patel, J.
2018
37 4S p. S439-S440
artikel
917 Pre-Transplant Neutrophil to Lymphocyte Ratio Predicts 30-day Readmission for Patients Undergoing Cardiac Transplantation Ahmed, N.
2018
37 4S p. S415-S416
artikel
918 Pre-Transplant Opioid Use is Associated with Increased Early Mortality and Readmission after Lung Transplantation Heiney, H.
2018
37 4S p. S168-S169
artikel
919 Pre-Transplant Proteinuria Predicts Post-Transplant Renal Replacement Therapy and Mortality in Patients Bridged with Left Ventricular Assist Devices Truby, L.K.
2018
37 4S p. S473
artikel
920 Pre-Transplant Serum Exosome Proteomics Differentiates Right and Left Ventricular Primary Graft Dysfunction Fine, B.
2018
37 4S p. S24
artikel
921 Prevalence and Predictors of Coronary Artery Disease in Patients Evaluated for Lung Transplantation Fernando, H.
2018
37 4S p. S451
artikel
922 Prevalence and Treatment Responsiveness of Lung Transplant Recipients with Post Transplant Lymphoproliferative Disease Berger, O.
2018
37 4S p. S254
artikel
923 Prevalence, Characteristics and Prognostic Impact of Wall Motion Abnormalities in Brain-dead Cardiac Donors With Transient Left Ventricular Systolic Dysfunction (LVSD) Madan, S.
2018
37 4S p. S136-S137
artikel
924 Prevalence of Microvascular Cardiac Allograft Vasculopathy Following Heart Transplantation Clerkin, K.J.
2018
37 4S p. S411-S412
artikel
925 Prevalence of Post-transplant Diabetes Mellitus (PTDM) and Cardiovascular (CV) Risk Factors After Lung Transplantation Leung, J.M.
2018
37 4S p. S451-S452
artikel
926 Primary Graft Failure is More Common in Patients Bridged to Heart Transplant with LVAD: Role of Early Peripheral ECMO Chinnadurai, T.
2018
37 4S p. S349
artikel
927 Primary LV Unloading with a Trans-valvular Axial Flow Pump Reduces Infarct Size by Increasing Myocardial Levels of Stromal Derived Factor One Alpha (SDF-1a) in Acute Myocardial Infarction and Limits the Development of Ischemic Heart Failure Esposito, M.L.
2018
37 4S p. S24
artikel
928 Process Improvement for Education and Competency in First Responders Regarding Ventricular Assist Device Emergencies Stewart, S.
2018
37 4S p. S275
artikel
929 Profiles of Ambulatory Advanced Heart Failure: A Report from the REVIVAL Registry Kittleson, M.
2018
37 4S p. S69-S70
artikel
930 Prognostic Implications of Intermediate Hemolysis in Continuous Flow Left Ventricular Assist Device Patients Rosenblum, H.
2018
37 4S p. S289
artikel
931 Prognostic Indicators in Extracorporeal Membrane Oxygenation for Cardiogenic Shock Guglin, M.
2018
37 4S p. S270-S271
artikel
932 Prognostic Significance of Red Cell Distribution Width in Patients with Left Ventricular Assist Devices Butler, R.
2018
37 4S p. S367
artikel
933 Prognostic Value of Invasive Resting and Exercise Hemodynamics in Long-term Heart-transplanted Patients Clemmensen, T.S.
2018
37 4S p. S329-S330
artikel
934 Prognostic Value of Pao2/Fio2 Ratio at the End of Double-Lung Transplantation Thes, J.
2018
37 4S p. S460
artikel
935 Prognostic Value of the Nutritional Risk Index in Candidates for Continuous Flow Left Ventricular Assist Device Therapy Uribarri, A.
2018
37 4S p. S463-S464
artikel
936 Proinflammatory Cytokines as Biomarkers for Severe Primary Graft Dysfunction After Heart Transplantation Holmström, E.
2018
37 4S p. S104
artikel
937 Prolonged but Successful Weaning from Berlin Heart EXCOR After a Long-term Mechanical Unloading in Infantile DCM Narita, J.
2018
37 4S p. S409
artikel
938 Prolonged Donation Withdrawal Ischaemic Time (DWIT) Does Not Impact on DCD Heart Transplant Outcomes Messer, S.
2018
37 4S p. S14-S15
artikel
939 Prolonged Management in Donors with Reduced Ejection Fraction is a Risk Factor for Graft Loss in Pediatric Heart Transplantation Singh, N.
2018
37 4S p. S62-S63
artikel
940 Prolonged Preservation and Evaluation of Human Lungs With Portable Normothermic EVLP Spratt, J.R.
2018
37 4S p. S242
artikel
941 Prone Positioning Attenuates Lung Injury During Warm Ischemia in a Large Animal Controlled Donation after Cardiac Death Model Watanabe, Y.
2018
37 4S p. S133-S134
artikel
942 Protective Effect of a Hydrogen-Rich Preservation Solution During Cold Ischemia in Rat Lung Transplantation Saito, M.
2018
37 4S p. S226
artikel
943 Protocol Development for DCD Heart Transplantation Smith, J.W.
2018
37 4S p. S341
artikel
944 Providers Perspectives on Palliative Care Integration in Advanced Heart Failure Care Quiaoit, Y.
2018
37 4S p. S300
artikel
945 Pseudoconstriction Secondary to Epicardial Pacing Following HeartWare Left Ventricular Assist Device (HVAD) Implant French, A.L.
2018
37 4S p. S141
artikel
946 Psoas Muscle Diameter in Patients Undergoing Left Ventricular Assist Device Implantation Yost, G.
2018
37 4S p. S467-S468
artikel
947 Psoas Muscle Mass Predicts Early Postoperative Outcomes and Survival in Lung Transplantation Suh, J.
2018
37 4S p. S447
artikel
948 Psychosocial Assessment for LVAD Candidates: A National Survey Clancy, M.J.
2018
37 4S p. S21
artikel
949 Psychosocial Outcome Categories to Better Understand Outcomes After VAD Dickinson, M.G.
2018
37 4S p. S474
artikel
950 Psychosocial Risk in LVAD Candidates: Preliminary Evaluation of Validity and Reliability of mPACT Maltby, M.C.
2018
37 4S p. S21
artikel
951 PTSD Following Heart and Lung Transplant: Outcome of Those Receiving Trauma-Focused Cognitive Behavioral Therapy Painter, L.
2018
37 4S p. S22
artikel
952 Pulmonary Artery Catheterization is Associated with Mortality Decline over Time in Cardiogenic Shock Compared to Patients with Acute Decompensated Heart Failure Hernandez, G.A.
2018
37 4S p. S43
artikel
953 Pulmonary Artery Decoupling Further Enhances Discriminatory Power of Pulmonary Vascular Resistance in Patients Bridged to Transplant with Left Ventricular Assist Devices Truby, L.K.
2018
37 4S p. S48-S49
artikel
954 Pulmonary Artery Pulsatility Index Predicts Right Ventricular Failure Post-LVAD Implantation in Ischemic Cardiomyopathy Kumar, S.
2018
37 4S p. S372-S373
artikel
955 Pulmonary Dynamic Compliance for Prediction of Mortality in Adult Severe Acute Respiratory Distress Syndrome Treated With Veno-Venous Extracorporeal Membrane Oxygenation Zoeller, K.
2018
37 4S p. S45
artikel
956 Pulmonary Endarterectomy: Relationship Between Total Reopened Branches and Outcomes Pin, M.
2018
37 4S p. S26
artikel
957 Pump Exchange after Left Ventricular Assist Device Implantation: Indications and Outcomes Shore, S.
2018
37 4S p. S366-S367
artikel
958 Pump Thrombosis in HeartWare HVAD Left Ventricular Assist Devices: Single Center Experience Demir, E.
2018
37 4S p. S372
artikel
959 Quality Improvement for VA ECMO in Pediatric Hospitals- A 20-Year Analysis of Neonatal and Pediatric VA ECMO Complications in North America Kiankhooy, A.
2018
37 4S p. S406
artikel
960 Quality of Clinical Outcomes and Effectiveness of Heart Failure Exacerbation Management in Emergency Room Observation Unit Versus Coronary Care Unit Al-Saffar, F.
2018
37 4S p. S316-S317
artikel
961 Quality of Life in Children and Young Adults With Pulmonary Hypertension and Its Association With Clinical Features Chau, P.
2018
37 4S p. S493-S494
artikel
962 Quality of Life with a Ventricular Assist Device (QOLVAD) Questionnaire: Preliminary Psychometrics for a New Measure Sandau, K.E.
2018
37 4S p. S477-S478
artikel
963 Quality of Outpatient INR Control in Children Supported on a Ventricular Assist Device Murray, J.
2018
37 4S p. S406-S407
artikel
964 Quantiferon Monitor Assay Identifies Over-Immunosuppressed Patients with Adverse Outcomes After Heart Transplantation: Towards the Definition of a Phenotype of Immune Frailty Potena, L.
2018
37 4S p. S19-S20
artikel
965 Quantification and Distribution of Thrombus Burden in Berlin Heart Pumps Shea, S.
2018
37 4S p. S407-S408
artikel
966 Quantification of DNA Damage in Heart Tissue as a Novel Prediction Tool for Therapeutic Prognosis Ko, T.
2018
37 4S p. S233
artikel
967 Quantifying the Devastation From Stroke During Support With Continuous Flow Pumps: An Intermacs Analysis Kirklin, J.K.
2018
37 4S p. S11
artikel
968 Questioning the Tacrolimus Dogma: Does Early Dose Control Matter? Baker, W.L.
2018
37 4S p. S417-S418
artikel
969 Race and Baseline Severity of Heart Failure in the Registry Evaluation for Vital Information on VADs in Ambulatory Life (REVIVAL) Lanfear, D.E.
2018
37 4S p. S189
artikel
970 Ralinepag, an Oral, Selective, Prostacyclin (IP) Receptor Agonist Consistently Improved Mortality Risk Scores Derived From PAH Registries Across Three Regions: Phase 2 Study Analysis Benza, R.L.
2018
37 4S p. S207-S208
artikel
971 Rapid High Dose Vaccine Series: Increasing Immunity to Hepatitis B in Lung Transplant Candidates Bowen, M.A.
2018
37 4S p. S113
artikel
972 Rapid Transition from Parenteral to Oral Treprostinil in Pulmonary Hypertension is Feasible and Safe: A Retrospective Cohort Study Jarrett, H.
2018
37 4S p. S494
artikel
973 Rates of CMV Reactivation in Non Mismatched Heart Transplant Patients Offen, S.
2018
37 4S p. S356
artikel
974 Rates of Hospitalization Associated with the Use of Aldosterone Receptor Antagonists in Patients with Pulmonary Arterial Hypertension Corkish, M.E.
2018
37 4S p. S152-S153
artikel
975 Rates of Primary Graft Dysfunction and Overall Survival Are Not Affected by the Laterality of the First Implanted Lung in Bilateral Lung Transplantation Axtell, A.L.
2018
37 4S p. S258
artikel
976 Readmissionsfor Children Hospitalized with Heart Failure: Are Some ReadmissionsPreventable? Knoll, C.
2018
37 4S p. S389
artikel
977 Real-world Continuous Physiologic Monitoring in Pediatric Cardiomyopathy Patients: A Safety and Feasibility Study Lebo, C.A.
2018
37 4S p. S299
artikel
978 Recipient Age and Acute Cellular Rejection - Implications for Targeted Surveillance After Heart Transplantation Jernryd, V.
2018
37 4S p. S327
artikel
979 Recipient Bone Marrow-derived Cells Are Important Targets of IL-17 in Development of Allograft Fibrosis in the Mouse Intrapulmonary Tracheal Transplantation Model Watanabe, T.
2018
37 4S p. S214
artikel
980 Recipient Cardiac Enzymes: An Early Indicator of Primary Graft Dysfunction Martinez, J.J.
2018
37 4S p. S435-S436
artikel
981 Recipient Emphysema Differentially Affects Immunologic Responses During Acute Lung Allograft Rejection in a Pre-Clinical Model Patel, K.J.
2018
37 4S p. S210
artikel
982 Recipient Working Status is Independently Associated with Outcomes in Heart Transplantation Iyengar, A.
2018
37 4S p. S333
artikel
983 Recipient Working Status is Independently Associated with Outcomes in Lung Transplantation Iyengar, A.
2018
37 4S p. S453
artikel
984 Recovery or Remission? Changes in Cardiac Function After LVAD Explantation Chavez, P.
2018
37 4S p. S483-S484
artikel
985 Recovery Plug for HeartMate 3 Left Ventricular Assist Device Mulzer, J.
2018
37 4S p. S480
artikel
986 Recurrent Acute Cellular Rejection Graded ISHLT 1R Early After Heart Transplantation Negatively Affects Long-term Outcomes Peled, Y.
2018
37 4S p. S324
artikel
987 Redo Heart Transplantation: The Comparison of Survival Based on the Time Interval Between Transplants Vucicevic, D.
2018
37 4S p. S431
artikel
988 Reduced Body Weight, Improved Physical Activity and Healthier Eating with Fitness Intensive Therapy (Get FIT) vs. Get FIT+: A Feasibility Study Evangelista, L.S.
2018
37 4S p. S118
artikel
989 Reduced 24-hour Blood Pressure Variability is Associated With Lower Pulse Pressure in Patients on Continuous Flow Left Ventricular Assist Device Support Castagna, F.
2018
37 4S p. S282
artikel
990 Reduced Pulsatility During Continuous Flow Left Ventricular Assist Device Does Not Affect Kidney Function Gallo, M.
2018
37 4S p. S118
artikel
991 Reduced Rate of Gastrointestinal Bleeding in Recipients of the HeartMate3 Compared to HeartMate II Ventricular Assist Devices Faerber, G.
2018
37 4S p. S162
artikel
992 Reduced Readmissions with Enoxaparin Bridging for Subtherapeutic INR in MCS Khuu, T.
2018
37 4S p. S310
artikel
993 Reducing Days in the Hospital with Cardiomems Device in Patients with Left Ventricular Assist Device Pandey, A.C.
2018
37 4S p. S280-S281
artikel
994 Refusal of Blood Products Should Not be a Contraindication to LVAD Therapy Salabat, R.
2018
37 4S p. S312-S313
artikel
995 Regional Variation and Outcomes of Thoracic Organ Transplantation from Drug Overdose Zhou, X.
2018
37 4S p. S138
artikel
996 Regulatory T Cells Induce Persistent Acceptance by IL-2 Complexes after Mouse Lung Transplantation Yamada, Y.
2018
37 4S p. S124-S125
artikel
997 Relation Between Intraventricular HVAD Position and Pump Thrombosis Aigner, P.
2018
37 4S p. S99-S100
artikel
998 Relation of Age to Risk of Major Rejections, Allograft Vasculopathy, and Long-term Mortality in a Contemporary Cohort of Patients Undergoing Heart Transplantation Peled, Y.
2018
37 4S p. S428
artikel
999 Relationship Between Oral Microbiota, Inflammation and Congestion Among Advanced Heart Failure Patients Demmer, R.T.
2018
37 4S p. S231
artikel
1000 Relationship Between Patient-Perceived Treatment Burden and Health-Related Quality of Life in Heart Transplant Recipients Deininger, K.M.
2018
37 4S p. S351
artikel
                             1292 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring